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The human gastrointestinal microbiome consists of approximately 10-100 trillion 
symbiotic microbial cells. Recent advances of molecular based approaches have 
enhanced the ease and rapidity with which the microbial community structure and 
function can be analyzed.  However, a growing problem is the divide between 
molecular analyses and cultivation based methods of investigation of this complex 
microbial system. Cultivation and molecular methods should be utilized 
complementary. Whole genome sequencing and metagenomic data enable inference 
of growth conditions of fastidious gut microbes. Investigations of the complex 
microbial communities of the gastrointestinal tract can greatly benefit from a 
combination of culture-based and molecular approaches in order to determine 
function and diversity of the previously uncultured organisms.  
Characterization of the gut microbiota has been of particular interest as it has such a 
tremendous amount of diversity and serves important roles in host health and 
disease. Data from gastrointestinal microbiome investigations is presented in the 
following chapters. Here I present research spanning organisms isolated from a 
Crohn’s disease patient to key species isolated from the microbiome of remote, 
traditional, indigenous communities (Fig 1). The study of a novel species is 
especially important when it is an abundant organism with an unknown role within 
the gastrointestinal tract. Chapter one addresses the characterization of two novel 
numerically dominant organisms. Investigations of such organisms provide 




the gastrointestinal microbial community. Chapters two and three focus on the 
isolation and characterization of key species from remote, hunter-gatherer 
communities. Investigations with traditional, indigenous communities provides a 
unique opportunity to expand the dataset, which is mainly represented by studies 
from within industrialized countries. Sampling within traditional communities 
removes many of the modern cosmopolitan biases. The gastrointestinal microbial 
ecosystems of traditional Peruvian communities have been shown to be distinct when 
compared populations from the industrialized world and are more similar to those of 
ancient samples than those sampled from cosmopolitan groups. In comparison, the 
gastrointestinal system of Western, cosmopolitan populations have undergone many 
changes from the ancestral state microbiome. When sampling from traditional 
communities, changes from the ancestral state microbiome in response to urbanism 
and Westernization are anticipated. Indeed, such changes, especially the selective 
pressures from therapeutic antibiotic treatment, provide drivers for antibiotic 
resistance and thus, the gastrointestinal microbiome may serve as a for reservoir 




Figure 1.  Phylogenetic tree of Lachnospiraceae, Ruminococcaceae and 
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Dominant groups of bacteria within the human colonic microbiota: 
Novel genera and species of the functionally important families 




The phyla Actinobacteria, Bacteroidetes, Proteobacteria and Firmicutes dominate 
the microbial community structure of the human gastrointestinal tract. This study 
aims to provide further insight into the members belonging to the Firmicutes that are 
numerically abundant within the gut microbiota and play an important role in host 
health and disease. Specifically, this chapter presents the taxonomic reorganization 
of key, misclassified organisms within the families Ruminococcaceae and 
Lachnospiracea, and the characterization of previously uncultured species that are 






The human colon harbors a diverse range of bacteria that form a complex 
community that has been subjected to both conventional cultivation and molecular-
based studies (Cummings & Macfarlane, 1991, Eckburg et al., 2005, Tap et al., 
2009, Moore et al., 2011, Walker et al., 2011). Understanding the role of the 
gastrointestinal microbial community and its complex relationship with the host is of 
great importance and has been a focus of many investigations for over a century 
(Suau et al., 1999, Dethlefsen et al., 2007, Bui et al., 2016). Using molecular 
methods within this system, between 40-80% of the total 16S rRNA gene sequences 
represent yet-to-be cultivated species (Liu et al., 2008). Discerning the relationship 
of key community members to specific aspects of host health is difficult with 
molecular methods alone. Characterization of novel bacterial functions and the 
description of the diversity of the trillions of bacterial cells that make up the 
gastrointestinal microbiome is more likely to occur by pairing culture-based with 
culture-independent approaches.  
Dominant species are routinely identified through 16S rRNA gene 
sequencing to provide a roadmap for the application of classical and improved 
cultivation methods for distinguishing the diversity of novel species. Comparison 
with close neighbors may also provide insights into their function within the 
gastrointestinal tract environment. The continued development of complementary 
molecular and culture approaches is essential to identifying microbial taxa and genes 




The complex environment is mainly dominated with organisms belonging 
within the phyla Actinobacteria, Bacteroidetes and Firmicutes and to a lesser degree 
Proteobacteria (Fig 2). Within the human gastrointestinal microbiome, members 
belonging to the Firmicutes phylum play a key role in health and disease through 
their involvement in nutrition, pathogenesis and immunology (Walker et al., 2011, 
Flint et al., 2012). Furthermore, it appears that the families Ruminococcaceae and 
Lachnospiracea contain many important organisms with respect to indicators with 
human health (Blaut & Clavel, 2007, Rainey, 2009, Flint et al., 2012, Clavel et al., 
2014, Stackebrandt, 2014). Together these two families contain half of all known 
genera containing valid species.   
 
	
Figure 2. Dominant genera of gastrointestinal tract based on 16S rRNA gene 





The abundance of an organism or group of organisms may indicate their 
functional role. The study of a novel species is especially important when it is an 
abundant organism with roles within the gastrointestinal tract. While the most 
abundant species are more likely to have cultured representatives, these groups 
remain inadequately represented (Walker et al., 2011). In the present study, during 
the course of an ongoing microbiome investigation in collaboration with colleagues, 
members of these important groups have been phylogenetically, 
chemotaxonomically and biochemically characterized.  Specifically, two novel 
organisms, shown to be important members of the human gastrointestinal tract and 
among the most abundant 16S rRNA phylotypes are presented here (Tap et al., 2009, 
Qin et al., 2010, Walker et al., 2011). Additionally, the taxonomic restructuring of 
these organisms and closely related organisms is an important step to better 
understand the interrelationships between taxa. The aim of this study was the 
characterization and taxonomic reorganization of these abundant, previously 
uncultured species and will contribute to the overall understanding of their role and 





Overview and the need for taxonomic restructuring 
Ruminococcaceae 
	
Within the family Ruminococcaceae, the genus Ruminococcus represents an 
especially important taxon and corresponds to 5-15% of the total bacterial population 
in the colon (Chassard et al., 2008, Ramirez-Farias et al., 2008). A better 
understanding of the diversity and functionality of species within this group is of 
considerable importance. Few Ruminococcaceae are represented by cultured species 
although estimates indicate that Firmicutes account for up to 25% of bacteria within 
the intestine (Lay et al., 2005). The application of 16S rRNA gene sequencing 
demonstrated that ruminococci are presently separated into two distinct, distantly 
related phylogenetic clades. Presently eleven species have been validly named and 
have standing in the nomenclature. Species are divided between the families 
Ruminococcaceae and Lachnospiracea (Fig 3) (Rainey & Janssen, 1995, Rainey, 





Figure 3. Members of group I (Ruminococcus, Wegmannia and Chassardia) and 
group II misclassified ruminococci within Ruminococcaceae and Lachnospiracea.  
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The family Ruminococcaceae contains the genera Ruminococcus (type 
genus), Acetanaerobacterium, Acetivibrio, Anaerofilum, Anaerotruncus, 
Ethanoligenens, Faecalibacterium, Fastidiosipila, Oscillospira, Papilibacter, 
Sporobacter and Subdoligranulum. Members of group I (Ruminococcus) are located 
within rRNA cluster IV (formally known as the Clostridium leptum cluster) as 
proposed by Collins et al. (1994) and include the type species Ruminococcus 
flavefaciens (Collins et al., 1994). Members of group I should be considered as 
Ruminococcus sensu stricto, i.e the true Ruminococcus species (Liu et al., 2008, 
Rainey, 2009).   
Members of group II ruminococci are located within rRNA cluster XIVa, of 
the family Lachnospiraceae which contains such genera as Lachnospira (type 
genus), Acetitomaculum, Anaerostipes, Bryantella, Butyrivibrio, Catonella, 
Coprococcus, Dorea, Hespellia, Johnsonella, Lachnobacterium, Moryella, 
Oribacterium, Parasporobacterium, Pseudobutyrivibrio, Rusburia, Shuttleworthia, 
Sporobacterium and Syntrophococcus among other misclassified species (Liu et al., 
2008, Stackebrandt, 2014). Therefore, members of group II should not be considered 
true representatives of the genus Ruminococcus, as such a number of former species 
have now been reclassified as Blautia and Trichococcus (Liu et al., 2002, Liu et al., 
2008, Lawson & Finegold, 2015). Novel species and genera continue to be assigned 
to the ruminococci on a regular basis.  
As part of continuing collaborations in the characterization of important 




isolated from a human fecal sample by the group headed by Harry Flint (Dabek et 
al., 2008, Wegmann et al., 2014). Strain 80/3 was of unique interest as it was found 
to account for 0.7% of total sequences and on of the top 25 most dominant 
phylotypes detected in the fecal samples of six adult males (Walker et al., 2011).  
Evidence also suggests that this novel organism and Ruminococcus-related strains 
are important members of the human GI tract microbiota being among the 10 most 
abundant 16S rRNA phylotypes present and indicating that they comprise 
approximately 2% of the colonic microbiota (Tap et al., 2009, Walker et al., 2011). 
In the present study phylogenetic, chemotaxonomic and biochemical analyses were 






The gastrointestinal microbial community composition is fairly stable and 
distributed within the Bacteroidetes and Firmicutes among healthy individuals. 
While it is not yet proven whether changes in the gastrointestinal system are the 
cause or consequence of microbiota disorders, some members of the gut microbiota 
have been identified as significant for their central role in gut homeostasis and 
because the loss of these organisms adversely affect the microbial community and 
hosts’ health.  An imbalance within the gastrointestinal microbial community has 
been linked to conditions such as obesity, colorectal cancer, irritable bowel 
syndrome (IBS), and inflammatory bowel diseases (IBD) including ulcerative colitis 
(UC) and Crohn’s disease (Sokol et al., 2008, Round & Mazmanian, 2009, Sekirov 
et al., 2010). This imbalance has also been generally associated with type 2 diabetes, 
and behavioural disorders like depression and regressive autism (Collins et al 2012, 
Dinan et al 2015).  
 
Within the gastrointestinal ecosystem, it is recognized that butyric acid, 
produced in the intestinal lumen by microbial fermentation of dietary carbohydrates, 
can have a range of actions (Sokol et al., 2008).  Butyrate producing bacteria are an 
abundant and phylogenetically diverse group that play a key role in maintaining 
human gastrointestinal health (Wang et al., 2014).  These roles include health-
promoting effects such as anti-inflammation, the stabilization of luminal pH and the 




& Flint, 2009). Among these species, decreased numbers of butyrate producers have 
been associated with gastrointestinal disorders. Thus, butyrate may have a protective 
role against a number of colonic diseases (Barcenilla et al., 2000, Pryde et al., 2002, 
Seksik et al., 2003, Flint et al., 2007, Louis & Flint, 2009). 
 
Molecular studies have provided unprecedented insights into the microbiota 
of the human gastrointestinal tract and have demonstrated differences between 
healthy persons and patients with gastrointestinal disorders like Crohn’s disease and 
ulcerative colitis (Seksik et al., 2003, Zoetendal et al., 2008). During a study of the 
microbiota of intestinal biopsy material taken from Crohn’s disease patients, isolates 
were identified by amplification and sequencing of the 16S rRNA genes (strain 
5/1/63FAA) and were shown to share more than 99% 16S rRNA sequence similarity 
to two butyrate-producing strains recovered from human fecal samples in previous 
studies (strains SS2/1 and SSC/2) (Duncan et al., 2004). These strains were 
identified as belonging to an unknown species distantly related to Anaerostipes 
caccae NCIMB 13811T, and were found to employ the butyryl CoA: acetate CoA 
transferase route for butyrate formation, either from sugars or from D-lactate and 
acetate (Duncan et al., 2004). During the course of our investigations the 16S rRNA 
gene sequence of Eubacterium hadrum ATCC 29173T was made publically available 
for the first time and it was apparent that this sequence was almost identical to that of 
the three isolates under investigation. According to Tap et al. (2009), dominant 




among the 10 most abundant OTUs in 50% of study participants. The abundance of 
these organisms indicates an important contribution to the core microbiome. 
Analysis of strain 5/1/63FAA was performed in order to resolve the relationships of 
these isolates and further characterize this important member of the human colonic 
microbial ecosystem. 
 
Based on phylogenetic, phenotypic and chemotaxonomic evidence, strains 
80/3T and strains SS2/1, SSC/2 , 5/1/63FAA were found to constitute two novel 
species within the Ruminococcaceae and Lachnospiraceae families respectively.  In 
addition to the characterization and description of these novel genera and species, the 
aim of the present work was to resolve the taxonomy of this group of organisms 
using genetic analyses. The further taxonomic restructuring of these species and 
closely related organisms was necessary in order to facilitate the reordering of those 




Materials and Methods 
Strain 80/3 T belonging to the family Ruminococcaceae 
Strain and culture conditions 
	
Stain 80/3T was isolated initially from a fecal sample from a female 
participant who had not received therapeutic antibiotics or other products likely to 
influence gastrointestinal composition in the previous six months as previously 
described (Dabek et al., 2008). The isolate was purified by serial dilution in roll 
tubes.  It was then maintained on M2GSC (Dabek et al., 2008) at 37°C under 
anaerobic head space (N2/CO2/H2, 85:10:5).  Provisional phenotypic and genome 
analyses were performed in a recent study (Wegmann et al., 2014) (Fig 3). 
 
Phenotypic and biochemical characterization 
	
The Lawson lab received the strain after initial isolation. Strain 80/3T was 
grown anaerobically in M2GSC broth (Wegmann et al., 2014) at 4-60°C. Growth in 
0-5% (w/v) NaCl was measured in 0.5% increments in M2GSC broth. The pH range 
for growth was investigated in M2GSC broth adjusted to pH 5-8.5 in increments of 
0.5 pH units.  Utilization of substrates was performed in basal cellulolytic (BC) 
medium (Robert & Bernalier-Donadille, 2003) with the addition of 5 g/L arabinose 
or 10 g/l of glucose, lactose, cellobiose, mannose, maltose, mannitol, raffinose and 




 Cellular fatty acid methyl ester (FAME) analysis was performed on 72 
hour growth in M2GSC medium. The methyl esters were extracted and analyzed by 
gas chromatography according to the Sherlock Microbial Identification System 
protocol (MIDI) (Kämpfer & Kroppenstedt, 1996). Fatty acids were identified and 
expressed in the form of percentages using the QTSA peak naming database. 
Imaging 
	
All imaging was performed as previously described (Wegmann et al., 2014). 
For scanning electron micrograph images, cells of strain 80/3T were fixed with 
glutaraldehyde, dehydrated through an ethanol series, critical point dried, attached to 
SEM stubs and gold coated.  For transmission electron micrograph images, cells 
were fixed in glutaraldehyde, embedded in low melting point (LMP) agarose, post-
fixed in osmium tetroxide, dehydrated through an ethanol series, embedded in acryl 
resin LR white ultrathin sectioned to coated copper 200 hex grids and stained.  
Phylogenetic analysis of strains 
	
The complete 16S rRNA gene sequence was obtained from DNA extracted 
from a standard phenol-chloroform method.  Primers corresponding to positions 8-27 
(forward primer) and 1492-1510 (reverse primer) of the Escherichia coli numbering 
system were used for amplification of the 16S rRNA gene (Hutson et al., 1993). The 
amplified products were treated with ExoSAP-IT (USB Corporation) and directly 
sequenced with primers directed towards the conserved positions of the rRNA gene. 




www.ezbiocloud.net/taxonomy (Yoon et al., 2016).  The 16S rRNA gene sequences 
of stain 80/3T and type strains of closely related genera, including representative type 
strains of Ruminococcaceae and Lachnospiracea were aligned using the Clustal X 
interface and manually corrected using GeneDoc (Nicholas et al., 1997). A 
phylogenetic tree was constructed according to the neighbor-joining method using 
SEQtools and TreeView (Saitou & Nei, 1987, Page, 1996). The stability of the 
groupings was estimated by bootstrap analysis (1000 replications) using the same 
programs.  All major branching nodes were confirmed by maximum parsimony (data 
not shown). The trees were rooted using the 16S rRNA gene sequence of 
Clostridium butyricum.  Additional analysis of the whole genomes from group I and 
II Ruminococcaceae was performed with the EZTaxon Average Nucleotide Identity 
(ANI) calculator (Yoon et al., 2017). Each of the five strains and strain 80/3T type 
strains were downloaded from NCBI and compared to one another. The percent 









Strain 5/1/63FAA belonging to the family Lachnospiraceae 
Strain and culture conditions 
	
Strains SSC/2  and SS2/1 were isolated as previously described from one 
healthy female who had not taken any antibiotics or other medication known to 
influence colonic microbiota for a period of three months or more (Duncan et al., 
2004). Strain 5/1/63FAA was isolated from biopsy material taken from the ascending 
colon of a 51 year old Canadian female, diagnosed as suffering from Crohn's 
disease. The biopsy specimen showed no sign of inflammation at the time of 
collection. Samples were streaked to purity by continued passages on Fastidious 
Anaerobe Agar (Oxoid) supplemented with 5% sheep blood until isolated colonies 
were obtained. The strain was received by the Lawson lab after initial isolation.  
Phenotypic and biochemical characterization 
	
The strain was characterized biochemically by using the commercially 
available biochemical systems API Rapid ID 32A and API ZYM (bioMérieux) 
according to the manufacturers’ instructions. All biochemical tests were performed 
in duplicate. Substrate utilization was determined by adding a final concentration of 
0.5% filter-sterilized sugar stock solutions (10%, w/v) to yeast extract, casitone, fatty 
acid (YCFA) medium dispensed in 7.5 ml aliquots in Hungate-type tubes, inoculated 
with test strains and incubated for 48 h at 37°C at a pH of 6.5 under anaerobic 
conditions. YCFA medium consisted of (per 100 ml): 1 g casitone, 0.25 g yeast 




(NH4)2SO4, 0.09 g NaCl, 0.009 g MgSO4 7H2O, 0.009 g CaCl2, 0.1 mg resazurin, 1 
mg haemin, 1 mg biotin, 1 mg cobalamin, 3 mg p-aminobenzoic acid, 5 mg folic acid 
and 15 mg pyridoxamine (Lopez-Siles et al., 2012). Tested sugar substrates were 
arabinose, cellobiose, fructose, glucose, maltose, melezitose, raffinose, rhamnose, 
ribose, sucrose and xylose. Acid end products from glucose metabolism were 
determined by capillary GC (Richardson et al., 1989).  
To further characterize the strain, analysis of fatty acids and mol% G + C was 
performed on 48 h cultures grown on Brucella blood agar plates. Cellular FAME 
products were extracted using the Sherlock Microbial Identification System (MIDI 
Labs Inc, Newark, DE) version 6.1 and analyzed by gas chromatography as 
described previously (Kämpfer & Kroppenstedt, 1996). Identification of fatty acids 
was determined using the QBA1 peak naming database.  The G + C content (mol%) 
was determined by HPLC according to the method of Mesbah et al. (Mesbah et al., 
1989) 
Imaging 
Phase contrast images of strain 5/1/63FAA were taken using Leica Applications 
Suite (LAS EZ Version 1.7.0) software as previously described (Allen-Vercoe et al., 
2012). Transmission electron micrographs were imaged on a Philips CM10 electron 







Phylogenetic analysis of strains 
Chromosomal DNA was purified by a standard phenol-chloroform method. 
For amplification of the 16S rRNA gene, a universal primer, corresponding to 
positions 8-27 (forward primer) and 1492-1510 (reverse primer) of the Escherichia 
coli numbering system was used (Hutson et al., 1993). The amplified products were 
treated with ExoSAP-IT to remove unincorporated primers and dNTPs (USB 
Corporation) and directly sequenced with primers directed towards the conserved 
positions of the rRNA gene. Approximately 1425 bases of the 16S rRNA gene were 
determined. 
The closest known related strains were retrieved from GenBank and EzTaxon 
databases and aligned with the newly determined sequences using the program 
SEQtools (http://www.ezbiocloud.net/eztaxon; Yoon et al., 2017, Kim et al., 2012, 
Rasmussen, 2002).  The resulting multiple sequence alignment was corrected 
manually using the program GeneDoc (Nicholas et al., 1997), and a phylogenetic 
tree was constructed according to the neighbor-joining method (Saitou & Nei, 1987) 
with the programs SEQtools and TREEVIEW (Page, 1996).  The stability of the 
groupings was estimated by bootstrap analysis (1000 replications).  All major 
branching nodes were confirmed by maximum parsimony (data not shown). 
Additional analysis of the genomes belonging to the strains and additional strains 
was performed using the EZTaxon Average Nucleotide Identity (ANI) calculator 






Strain 80/3T belonging to the family Ruminococcaceae 
Growth occurred in pH 7-8, NaCl 0-3.0% and 30-37°C. The ability of strain 
80/3T, to utilize substrates, in addition to those carbohydrates previously tested, was 
determined. Utilization of glucose, lactose, mannose and cellobiose was observed, 
but no growth was observed with other carbohydrates, including cellulose, xylan, 
starch, maltose, raffinose, sucrose, and xylose.   
Acetate, ethanol and formate were found to be the major end products as 
described previously (Wegmann et al., 2014). Interestingly, unlike similar species of 
ruminococci found in the bovine rumen and human colon, strain 80/3T did not utilize 
cellulose or xylan, but did have the specialized ability to utilize β-glucans and 
xyloglucan (Wegmann et al., 2014). The fatty acid profile included major fatty acids 
C16:0 and C17:0 ω7c cyclo (Table 1).  The phenotypic characteristics of strain 80/3T were 
compared with those of its closely related taxa in Table 2. Unlike these closely 
related species, strain 80/3T did not to ferment cellulose and xylan and also did not 
ferment sucrose as seen in R. albus. Major fermentation product differences were 
also observed among related species. All strains compared here produced acetate but 
only strain 80/3T, R. albus and R. flavefaciens produced ethanol. Of the group I 










Table 1. Cellular fatty acid composition of strain 80/3T. 





C14:0 iso 1.9 
C15:0 iso 3.9 
C15:0 anteiso 6.1 
C15:0  4.3 
C16:0 iso 2.3 
C16:0 24.8 
C17:0 1.4 
Unsaturated   
C17:0 ω7c (cyclo) 18.1 
C19:1 iso 1.9 
Hydroxy acid  
C16:0 3-OH 2.0 
Summed featuresa  
Summed feature 3 1.7 
Summed feature 5 3.2 
Summed feature 8 6.8 
Summed feature 11 1.0 
Only those fatty acids that make up >1% are shown 
a Summed feature 3 is comprised of C16:1 ω7c/C16:1 ω6c; summed feature 5 is 
comprised of C18:0 ante/C18:2 ω6,9c; summed feature 8 is comprised of C18:1 
ω9c/C18:1 ω7c/C18:1 ω6c; summed feature 11 is comprised of C19:0 cyclo ω8c/C20:0. 










Figure 4. A) Scanning electron micrograph image of strain 80/3T B) Transmission 
electron micrograph image of strain 80/3T cells grown in YCFAG medium 
(Wegmann et al., 2014). 
 
The results of the 16S rRNA based analyses clearly identify strain 80/3T as a 
member of the family Ruminococcacae and is most closely related to Ruminococcus 
albus with 94.2% 16S rRNA gene sequence similarity (Table 3). Lower sequence 
similarities were obtained with members of a separate lineage that contain the type 
strain R. flavefaciens (91.8%), R. champanellensis (91.8%) and R. callidus (90.7%). 
Futhermore, R. bromii is located in a separate line of decent with only 88.1% 
sequence similarity. Based on recommendations of Yarza et al. (2014) a sequence 








Table 3. Comparison of 16S rRNA gene sequence similarity between group I 













Strain 80/3T -     
R. flavefaciens 91.8% -    
R. albus 94.2% 91.6% -   
R. 
champanellensis 
91.9% 94.9% 92.0% -  
R. callidus 90.7% 93.3% 89.8% 94.1% - 
R. bromii 88.1% 89.1% 89.0% 89.8% 89.0% 
 
Wegmann et al. 2014 determined the complete genome of strain 80/3T. The 
DNA G+C of strain 80/3T was 43 mol%.  The genome consisted of two circular 
chromosomes. The split of the genome into two chromosomes is thought to shorten 
the time needed for DNA replication supporting faster growth and could provide a 
selective advantage favoring the multireplicon genome architecture (Wegmann et al., 
2014). 
 
The phylogenetic analyses performed in this study revealed not only that 
strain 80/3 represented a novel species of a novel genus, but also demonstrated that 
the genus Ruminococcus was in need of restructuring.  It is proposed that strain 80/3T 
and R. albus be classified, along with another member of misclassified ruminococci, 
to two novel genera. Together, strain 80/3T and R. albus form a distinct lineage 
within the subcluster of several recognized group I Ruminococcus species that are 
closely related to each other but distinct enough from R. flavefaciens genera to merit 




gene similarities with the true ruminococci and was only distantly related to R. 
bromii.   
	
Figure 5. Phylogenetic tree showing the relationship of strain 80/3T to closely 
related members of the family Ruminococcaceae. C. butyricum was used as the out-
group. The scale bar indicates 1% sequence divergence. 
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As previously suggested (La Reau et al., 2016), R. bromii is not closely 
related to the true ruminococci, but is more closely related to Clostridium spp.  and 
forms an entirely separate genus (Fig 5).  At the time when R. bromii was first 
described, the strain was placed incorrectly within the genus Ruminococcus. As this 
was prior to the development of molecular methods R. bromii was assigned to the 
Ruminococcus genus based on its culture and metabolic characteristics although the 
authors acknowledged the differences between the strain and Ruminococcus species 
(Moore et al., 1972).  
Based on recent recommendations, it is thus proposed that those species that 
do not share close phylogenetic relationship (~89-91%) to R. flavefaciens should be 
reclassified into two novel genera within the Ruminococcaceae. In addition to initial 
genome description data, this polyphasic taxonomic approach utilizing 16S rRNA 
gene sequence analysis indicates that strain 80/3T should be placed in a novel genus 
with R. albus, and that R. bromii should be placed in a separate but related genus to 
which the names Wegmannia and Chassardia are respectively proposed. 
The remaining members of group I ruminococci are those species limited to 
Ruminococcus sensu stricto R. flavefaciens, R. champanellensis and R. callidus. 
These strains form their own branch within the group I ruminococci with a ~94% 
16S rRNA similarity (Table 3). This value is on the cusp of the values used for the 
delineation of genera and arguments can be made for inclusion into a single genus or 




The average nucleotide identity (ANI) value was determined to be 68-70% 
and G+C content of the DNA is 39-53 mol% (Table 4-6). While there is no ANI % 
cutoff for species within genera description consistent with the 95 % ANI value 
corresponding to the 70 % DDH recommendation for species cutoff, the low ANI 
values do support the separation of these strains into novel genera. However, at this 
time and until additional species are described, these species should be retained in 
the genus Ruminococcus. Additional strains may reveal diagnostic and unique traits 









Table 6.  Comparison of group I ruminococci strains ANI data OrthoANIu values 
 
The misplaced species in group II ruminococci - R. gnavus, R. gaureauii, R. 
lactaris, R. faecis and R. torques form multiple distinct novel genera based on 
phylogenetic analysis (Fig 2) and shown in Table 7. Likewise, the ANI values of 
whole genome analysis of the group II indicated multiple genera (Table 8 and 9). R. 
lactaris, R. faecis and R. torques likely form one novel genus (misclassified I), 
sharing 96.2-96.3% similarity of 16S rRNA genes and 73.4-77.5% similarity of ANI 
(Table 10). Likewise, phylogenetic analysis suggests that R. gnavus and R. gaureauii 
warrant two novel genera, misclassified II and misclassified III, respectively.  
Misclassified II and misclassified III have distinct lineages from misclassified I and 
each other.  










Table 10. Comparison of Group II ruminococci strains ANI data OrthoANIu values 
 
 
These genera divisions are not well resolved phylogenetically as the later 
genera are only represented by a single species and should serve only as guidance for 
future studies. An emphasis should be placed on these species as additional novel 
strains within this group are isolated and the phylogeny of the genera can be further 

















-     
R. faecis 66.1% -    
R. torques 65.3% 73.8% -   
R. lactaris 65.7% 77.5% 73.4% -  
R. gauvreauii 64.4% 68.8% 68.7% 69.5% - 





Genus and species descriptions 
 
Description of Wegmannia  gen. nov. 
 
Wegmannia (Weg.man.nia N.L. fem. n. Wegmannia in honor of Udo Wegmann, a 
German microbiologist for his contributions to the colonic microbiota). Cells are 
Gram-positive non motil cocci. Bacteria are anaerobic, optimal growth is observed at 
37°C and pH tolerance ranges from 6-8. Fermentation of glucose, cellobiose, lactose 
and mannose. The G+C content  of the DNA is 43-46 mol%. Strains are isolated 
form human feces. The type species of the genus is Wegmannia albus.  
 
Description of Wegmannia bicirculans sp. nov.  
 
Wegmannia bicirculans (bi.circ’.u.lans) The description of Wegmannia birciculans is 
identical to that proposed previously (Fig 4) (Dabek et al., 2008, Wegmann et al., 
2014). In addition to the characteristics given in the genus description, colonies 
grown on M2 agar plates were opaque grey in color. Its predominant cellular fatty 
acids are C16:0 and C17:0 ω7c cyclo. Positive for fermentation of glucose, cellobiose, 
lactose and mannose. The type strain was isolated from the fecal sample of a healthy, 
adult female. The DNA G+C content of the type species is 43%. The whole genome 
sequence was deposited in the EMBL database with the accession numbers 
HF545616 and HF545617 for chromosome I and chromosome II, and the 16S rRNA 








Description of Wegmannia albus comb. nov.  
 
Wegmannia albus 
Basonym: R. albus (al’bus. L. adj. albus white.) (Hungate, 1957). 
The description of Wegmannia albus is identical to that proposed for Ruminococcus 
albus (Hungate, 1957). Cells are Gram-poisitive-staining and non motile cocci. 
Positive for fermentation of cellulose, xylan, glucose, cellobiose, lactose, mannose 
and sucrose. Major fermentation products are acetate and ethanol. The DNA G+C 
content of the type species is 43-46%. The type strain is 7 (= ATCC 27210T = DSM 
20455T  = JCM 14654T ) isolated from human feces. 
 
Description of Chassaridia bromii gen. nov. comb. nov. 
 
Chassardia bromii (Chass.ar.di’a. M.L. fem. n. Chassardia in honor of Christopher 
Chassard, a French microbiologist, in recognition of his contributions to human 
gastrointestinal microbiology). The description of Chassardia bromii is identical to 
R. bromii (Moore et al., 1972). The type strain is ATCC 27255T isolated from the 





Strain 5/1/63FAA belonging to the family Lachnospiraceae 
Colonies of strains ATCC 29173T , SS2/1T and SSC/2T appeared white-
opaque with a translucent, irregular margin, flat, rough and 1-3 mm diameter in size 
when grown on Brucella blood agar after 24 h at 37°C. Under the same incubation 
conditions, colonies of 5/1/63FAA were grey, round, convex and glossy, with a 
ridged margin, and 1-3 mm diameter in size. The cells of all strains consisted of 
Gram-positive-staining, non-motile, non-spore-forming, rod shaped cells (on 
average, 4.75 x 0.75 mm in size) (Fig 6). Growth was observed with glucose, 
cellobiose, maltose, fructose or sucrose, and weak growth with melezitose or 
raffinose, as energy sources. No growth was obtained with arabinose and rhamnose, 
while all strains grow well on xylose and none used ribose.  
 
	
Figure 6. A) Phase contrast image of strain 5/1/63FAA.  B) Transmission electron 








Strains SS2/1T and SSC/2T have been shown to utilize D-lactate and acetate 
to form butyrate (Duncan et al., 2004). E. hadrum ATCC 29173T was shown here to 
have the same ability to utilize acetate, as well as the D- but not the L- isomer of 
lactate. This contrasts with the current description of E. hadrum, possibly because 
lactate utilization requires the presence of acetate in the medium. D-lactate was 
estimated by measuring total DL-lactate and L-lactate (Schwiertz et al., 2002, 
Duncan et al., 2004). 
Using the rapid ID 32A, almost identical profiles were obtained for the four 
strains, which were generally unreactive (Table 11). Positive reactions were obtained 
for b-galactosidase, indole (weak) and alkaline phosphatase (weak). In addition, 
strain 5/1/63FAA showed a positive reaction for a-galactosidase (weak).  
All other tests were negative. Likewise, the strains also gave mostly negative 
reactions using the API ZYM system (Table 12), only giving weakly positive 
reactions for acid phosphatase, naphthol-AS-BI-phosphohydrolase, and strain 
5/1/63FAA also gave a weak reaction for a-galactosidase. The end products of 
glucose metabolism were butyrate (11.07± 0.95mM) and formate (7.61± 1.48mM) 
(mean of triplicate incubations. All strains possessed both the ability to produce and 







Table 11. API Rapid 32A differential reactions of strains E. hadrum ATCC 29173T 
and strains SS2/1 T, SSC/2T and 5/1/63FAA 
Reactions/Enzymes ATCC 29173T SS2/1  SSC/2 5/1/63FAA 
Arginine dihydrolase +w +w - - 
a-Galactosidase - - - +w 
b-galactosidase-6-phosphate +w - - - 
a-Glucosidase - - - +w 
Indole production - +w +w +w 





Table 12. API ZYM differential reactions of strains E. hadrum ATCC 29173T and 
strains SS2/1T, SSC/2T and 5/1/63FAA 
Reactions/Enzymes ATCC 
29173T 
SS2/1  SSC/2 5/1/63FAA 
Alkaline phosphatase +w - - - 
Esterase +w - - - 
Esterase lipase +w - - - 
Acid phosphatase + + +w +w 
Naphthol-AS-BI-phosphohydrolase + +w +w +w 
a-Galactosidase - - - +w 
+, positive reaction; - negative reaction; w, weak reaction. 
. 
Predominant cellular fatty acids were C12:0, C17:0 and summed features 2 and 
10 (Table 13). Strain differences may reflect real differences in cell membrane 
composition. The G + C mol% was determined to be 37.0-41.8%. In the original 
description the G + C mol% of E. hadrum ATCC 29173T was reported as 32-33% 
(Moore et al., 1976). This difference is likely due to determination of G + C mol% 
by biochemical means and the recognition that such methods are subject to 
experimental error, especially between different laboratories. The initial value of 32-






Table 13.  Cellular fatty acid composition of E. hadrum ATCC 29173T and strains 
SS2/1 T, SSC/2T and 5/1/63FAA 
Cellular fatty acid ATCC 29173T SS2/1 T SSC/2T 5/1/63FAA 
Saturated straight 
chain 
    
C10:0 7.7 2.2 2.4 1.5 
C12:0 23.5 41.4 33.5 24.0 
C13:0 2.2 - - - 
C14:0 4.5 2.8 2.8 2.0 
C16:0 4.6 5.7 7.8 8.5 
C17:0 3.6 8.4 12.7 14.2 
Unsaturated straight 
chain 
    
C17:1 ω8c - 1.1 - 2.0 
C17:1 ω6c - 2.8 2.1 2.3 
Hydroxy acid     
C11:0 3-OH 1.1 5.1 2.2 - 
Summed featuresa     
Summed feature 2 20.2 12.0 13.4 6.7 
Summed feature 4 3.3 - - - 
Summed feature 8 - - - 2.4 
Summed feature 10 4.5 7.2 12.7 27.6 
Summed feature 11 4.3 - - 1.6 
Only those fatty acids that make up >1% are shown. 
a Summed feature 2 is comprised of C14:0 3-OH, C16:1 iso l; summed feature 4 is an 
unknown (likely C15:0); summed feature 8 is comprised of C18:1 ω9c, C18:1 ω6c; 
summed feature 10 is comprised of C17:0 cyclo and/or C18:0, C17:0 cyclo. Products in 
bold denote predominant fatty acids. 
Phylogenetic analysis of the strains demonstrated they were almost identical 
based on 16S rRNA gene sequence similarity. A tree constructed using the neighbor-
joining method demonstrated that the organism is related to members of the genus 
Anaerostipes of the family Lachnospiraceae (formerly clostridial cluster XIVa) 
within the phylum Firmicutes (Schwiertz et al., 2002).  The most closely related 
species are A. butyraticus LMG 24724T (94.7% sequence similarity), A. caccae 
NCIMB 13811T (93.5% sequence similarity), and A. rhamnosivorans (93.4% 





This cluster was supported by a significant bootstrap value of 100%. While there is 
no precise correlation between 16S rRNA sequence divergence and species 
delineation, it is generally recognized that divergence values of 3% or more are 
significant (Stackebrandt & Ebers, 2006, Tindall et al., 2010). More recently, Kim et 
al. (2014) suggests that a 98.7 % 16S rRNA gene sequence similarity can be used as 
the threshold for differentiating two species. Additional ANI analysis of the strains 
supported the strains belonging to one species (Table 14). The strains described here 
should therefore be regarded as belonging to a novel species within the genus 






Figure 7. Phylogenetic relationship of Anaerostipes hadrus comb. nov. with closely 
related members of the family Lachnospiraceae. Bootstrap values, expressed as a 
percentage of 1000 replications, are given at branching nodes. Only values above 
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In addition to its unique 16S rRNA gene sequence, A. hadrus can clearly be 
distinguished phenotypically from previously described Anaerostipes species. 
Biochemically A. hadrus can be distinguished from A. butyraticus LMG 24724T and 
A. caccae NCIMB 13811T by the differences in the reactions to b-galactosidase, 
indole production and alkaline phosphatase. In addition, while both A. caccae 
NCIMB 13811T and A. hadrus are known to utilize lactate, A. hadrus differs from A. 
caccae L1- 92T in using only the D-isomer while the latter can use both the D and L- 
isomers (Duncan et al., 2004).  
Since its original isolation, the significance of strains belonging to A. hadrus 
within the human GI tract has been reported. In the healthy colon, this newly defined 
species may represent more than 2% of the total colonic microbiota (Flint et al., 
2012). Walker et al. (2011) reported in studies using 16S rRNA sequencing to 
examine the response of different bacterial groups to changes in diet, A. hadrus was 
one of the 10 most abundant species in fecal samples from 6 overweight human 
volunteers (Walker et al., 2011). Likewise, A. hadrus represented one of the four 
most prevalent OTUs among butyryl CoA: acetate CoA transferase and 16S rRNA 
genes amplified from samples from 10 non-obese human volunteers (Louis et al., 
2010). This species has been shown to use D-lactic acid at mildly acidic conditions 
to form butyric acid, which is the major energy source for colonocytes (Belenguer et 
al., 2011). It has been estimated that approximately 20% of the butyric acid pool in 




butyric acid from lactic acid and the high abundance level indicate that the organism 
likely plays an important functional role in this complex ecosystem. 
 
Description of Anaerostipes hadrus comb. nov. 
 
Anaerostipes hadrus (had’rus. N.L. adj. hadrus (from Gr. N. adj. hadron thick, bulky 
referring to the relatively large size of the cell). 
 
Physiological data and phylogenetic analysis based on 16S rRNA genes 
sequences support the reclassification of E. hadrum as A. hadrus comb. nov. In 
addition to the description given by Moore et al. (1976), cells were Gram-positive 
staining rods, non-motile and that are approximately 3 x 0.5 mm in size (Moore et 
al., 1976). Endospores were not observed. On Brucella agar supplemented with 
blood after 24h at 37°C the colonies of strains SS2/1, and SSC/ 2 appear white-
opaque with a translucent, irregular margin, flat, rough and 1-3 mm diameter in size. 
Under the same cultivation conditions, colonies of 5/1/63FAA are grey, round, 
convex and glossy, with a ridged margin, and 1-3 mm diameter in size. In broth 
cultures better growth is sometimes observed at pH 5.5 than either pH 6.2 and 6.7. 
Indole produced (weak). Nitrate reduced to nitrite. Strains produced formate (2-8 
mM) and butyrate (8-12 mM) on YCFA medium containing 0.2% glucose. The 
species grew and produced butyrate from acetate and lactate in YCFA medium in the 





The species showed positive reactions of API Rapid ID 32A for b-
galactosidase, indole (weak), alkaline phosphatase (weak). In addition, strain 
5/1/63FAA showed a positive reaction for a-galactosidase (weak). No activity was 
detected for urease, arginine dihydrolase, b-galactosidase-6-phosphate, b-
glucosidase, a-arabinosidase, b-glucuronidase, N-acetyl-b-glucosaminidase, 
mannose, raffinose, glutamic acid decarboxylase, a-fucosidase, arginine 
arylamidase, proline arylamidase, leucyl glycine arylamidase, phenylalanine 
arylamidase, leucine arylamidase, pyroglutamic acid arylamidase, tyrosine 
arylamidase, alanine arylamidase, glycine arylamidase, histidine arylamidase, 
glutamyl glutamic acid arylamidase and serine arylamidase 
 
The API ZYM system only gave weakly positive reactions for acid 
phosphatase, naphthol-AS-BI-phosphohydrolase, and strain 5/1/63FAA also gave a 
weak reaction for a-galactosidase. Enzyme activity was not detected for alkaline 
phosphatase, for esterase (C4), esterase lipase (C8), lipase (C14), leucine 
arylamidase, valine arylamidase, cystine arylamidase, trypsin, a-chymotrypsin, b-
galactosidase, b-glucuronidase, a-glucosidase, b-glucosidase, N-acteyl-b-
glucosaminidase, a-mannosidase or a-fucosidase. A variable reaction is obtained 
with a-galactosidase. The major long-chain fatty acids are C12:0 , C 17:0, and summed 
feature 2. The G+C content is 37-42 mol%.The type strain is ATCC 29173 T (=DSM 






As the majority of organisms within the human gastrointestinal system are 
uncultivated species, understanding the role novel organisms play within the 
gastrointestinal microbial community is essential to determine the relationship with 
host health.  The characterization and taxonomic restructuring of the numerically 
dominant organisms is necessary to determine their importance within the system. 
Within the gut microbiome, it is recognized that the limitations of the hosts’ ability 
to produce butyrate and degrade plant polysaccharides requires a diverse array of gut 
bacteria with the ability to perform these functions.   
The organisms described here are among the most abundant 16S rRNA 
phylotypes of the human gut (Tap et al., 2009, Qin et al., 2010, Walker et al., 2011). 
On the basis of phenotypic, genotypic and phylogenetic differences, the strains were 
clearly distinguished from all previously described species of the Lachnospiraceae 
and Ruminococcaceae. Previous studies have reported that A. hadrus was one of the 
10 most abundant species in fecal samples (Louis et al., 2010, Walker et al., 2011). 
The ability of A. hadrus to produce butyrate from lactic acid provides a major energy 
source for colonocytes. Approximately 20% of the butyric acid pool in the large 
intestine is derived from lactic acid metabolism, indicating the essential role A. 
hadrus and other butyrate producers play in the system.  
Similarly, the role of Wegmannia spp. and closely related Ruminococcus spp. 
and Chassardia spp. play a vital role within the gastrointestinal microbial 




insoluble and resist degradation by human enzymes when consumed as part of the 
diet. However, dietary components that are indigestible to humans are fermented by 
the colonic microbiota. Degradation of plant polysaccharides in the colon requires 
the action of a diverse array of gut bacteria enriched with genes encoding fibrolytic 
enzymes that cleave specific glycosidic linkages (Martens et al., 2011).  
The genome of W. bicirculans was the first completed genome sequence for a 
human colonic representative of the Ruminococcaceae and one of the first completed 
genome sequences for a strictly anaerobic Firmicutes bacterium from the human GI 
tract. Genomic data is available for only a small number of species of 
Ruminococcaceae isolated from the rumen and human colon. Similarly, as few 
species of Ruminococcaceae are represented by cultured species, the characterization 
of strain Wegmannia bicirculans presented here contributes to an improved 
understanding of the role these organisms play within the human GI tract and 
provides further taxonomic resolution of the misclassified ruminococci and related 
phylogenetic clades. As several former Ruminococcus spp. have been reclassified to 
other genera, the reclassification of the remaining Ruminococcus spp. is needed to 
avoid confusion and to resolve phylogeny.  As no novel organisms representative of 
the group II misclassified ruminococci are being classified in this study, 
reclassification of the these Lachnospiracea species is beyond the scope of the work 
presented here.  
Molecular profiles based on 16S rRNA gene sequences provide tremendous 




important to culture and isolate the organisms that constitute these microbial 
communities. Cultivation and molecular methods are complementary, as 
metagenomic data can allow for the inference of the necessary growth conditions of 
uncultivated bacteria and characterization of their functions (Lagkouvardos et al., 
2016). Molecular methodology continues to drive and aid novel approaches for the 
cultivation of these uncultivated organisms. As the organisms representing the most 
abundant phylotypes of the human gut continue to be cultivated and characterized, 
the diversity of taxa within the system and the interactions between specific strains 
of the microbiome is better understood. Further experiments with the microbial 
consortia can be constructed to determine interrelationships between different taxa 



















Clostridium amazonense a novel obligate anaerobic bacterium 





Initial studies of the human gastrointestinal tract have revealed that the microbiome 
of traditional, indigenous communities are significantly different than those derived 
from Westernized and urbanized communities. Investigations of these communities 
have revealed microbes atypical of those found in industrialized nations and may 
provide insights into how the gastrointestinal microbiome responds to urbanism and 
Westernization. Examination of the literature reveals that the majority of 
investigations are based on molecular methods providing important information on 
the diversity present via community profiles employing 16S rRNA gene sequence 
analysis. However, cultivation and characterization of representative taxa from non-
Western groups is necessary to gain a more complete understanding of the ecology 
and functional diversity of the gastrointestinal tract.  
A number of novel taxa including a novel genus and two novel species from the 
family Peptoniphilaceae and a novel species from Clostridium cluster I (Clostridium 
sensu stricto) were discovered from geographically remote Amazonian communities 
located in Peru. The focus of this chapter is the isolation and characterization of an 




phylogenetic analysis of the 16S rRNA gene sequence, for which the name 
Clostridium amazonense sp. nov. is proposed. Unlike the organisms reported in the 
previous chapter, the novel Clostridium species presented here is not an abundant 
phylotype according to molecular surveys based on 16S rRNA gene analysis. The 
organism was characterized using biochemical and chemotaxonomic methods. In 
addition, antimicrobial susceptibility testing was performed against a panel of 15 
antibiotics to determine resistance to antibiotic classes commonly used to treat 
infections. To date strain NE08VT has only been recovered from Community 1 and 
has yet to be reported in over 8,000 studies human microbiome studies performed to 







The human body is host to tens of trillions of microbial cells that form highly 
complex microbial communities. These microbial symbionts are referred to as the 
human microbiome and are the collection of all the microorganisms – including 
eukaryotes, archaea, bacteria and viruses - present in the nasal, oral, skin, 
gastrointestinal tract and urogenital tract.  The characterization of these 
microorganisms is essential to understanding not only the diversity and stability of 
the microbial communities within our bodies but also the extent of the role they play 
in human health and disease states. 
There has been a growing interest in the commensal human microbiome and 
in 2007, the National Institutes of Health (NIH) launched their roadmap initiative – 
the Human Microbiome Project (HMP).  The major aims of the HMP included 
determining if individuals across the world share a core human microbiome and 
whether changes in the human microbiome can be correlated with changes in human 
health (Turnbaugh et al., 2007, Peterson et al., 2009, Consortium, 2012).  Molecular 
inventories based mainly on the use of 16S rRNA gene sequencing have provided 
tremendous insights into the microbial diversity and the richness of taxa present in 
the human gastrointestinal tract. Indeed, such studies show that approximately 40-
80% of the phylotypes represent uncultured bacteria (Liu et al., 2008, Zhou et al., 
2014). However, the majority of these studies have focused on Western populations 
using 16S rRNA gene sequence libraries derived from culture-independent methods 




1940s, the widespread consumption of processed and chemically treated food and 
water sources of Western populations has led to a tremendous increase in the number 
of diseases affecting the human gastrointestinal tract. Certain organisms that have 
previously played a protective role in the gastrointestinal tract have been lost due to 
the modern diet and changes in lifestyle (Blaser, 2014).  In order to truly evaluate the 
core microbiome and elucidate the complex interactions between microorganisms, 
individuals from a variety of geographic regions with diverse diets must be included 
in these investigations (Hattori & Taylor, 2009, Gordon, 2012, Lewis et al., 2012).  
Studies of the gastrointestinal microbiome are revealing that the microbiome 
of indigenous communities may be significantly different than those derived from 
Westernized and urbanized communities (Contreras et al., 2010, Blaser et al., 2013, 
Schnorr et al., 2014, Obregon-Tito et al., 2015). Similarly, gastrointestinal microbes, 
atypical of industrialized nations, may have the ability to perform functional roles 
within the host microbiome of remote communities that are normally undertaken by 
different taxa or are absent in Westernized communities. 
 Culture-dependent approaches and the application of methods to characterize 
the microbial physiological and metabolic properties can be used to better understand 
the ecology of these microbial communities and the interaction between individual 
species that play a role in both health and disease processes (Lagier et al., 2012, 
Wylie et al., 2012, Clavel et al., 2014). 
An increased international effort is now underway to include indigenous 




This effort led our team to work with communities in Peru (Obregon-Tito et al., 
2015). These communities include two traditional hunter-gatherer groups deep 
within the Amazon River basin as well as a coastal community that maintains 
traditional subsistence fishing and farming practices. Studies of communities that 
continue subsistence and nomadic traditional lifestyles are critical for providing a 
foundation for understanding how the human microbiome responds to urbanism and 
Westernization and may also yield insights into the ancestral state of the human 
microbiome.  
We hypothesized that these indigenous communities were host to a distinct 
gastrointestinal microbiome, due to their geographically remote location and 
traditional lifestyle, when compared to Western populations and harbor novel 
intestinal microorganisms. Furthermore, the antibiotic resistome of the isolates from 
these communities will differ from those isolated from Western samples in the 
absence of the selective pressures associated with antibiotic therapy. Sampling 
within traditional communities removes many possible effects of modern-day 
lifestyles placed upon the gastrointestinal tract of many urbanized populations. 
Evidence for such changes is the gastrointestinal microbial ecosystems of traditional 
communities previously sampled in Peru have been shown to be more similar to 
those of ancient samples than those sampled from cosmopolitan groups (Obregon-
Tito et al., 2015). In comparison, the organisms composing the microbial 
communities of the GI tract of Western, cosmopolitan populations have undergone 




ingestion of processed food and water, improved sanitation technologies, 
globalization of urban microbiomes and changes in the GI microbial community due 
to the common prescription of antibiotics (Blaser, 2014).  Ultimately, by sampling 
from traditional communities we anticipate that changes from the ancestral state 
microbiome in response to urbanism and Westernization will be observed. 
In our continuing studies of traditional communities in Peru, a novel, Gram-
stain-positive, strictly anaerobic bacterium was isolated from a fecal sample.  Based 
on the phylogenetic, phenotypic and chemotaxonomic evidence, strain NE08VT 
represents a novel species within the genus Clostridium for which the name 






Materials and methods 
Community and participant selection 
A small, remote traditional Shipibo community (Community 1), from the Loreto 
region, Peru was selected for a collaborative research effort after careful planning 
and consideration of both national and traditional regional authorities (Fig 8).  As 
with other indigenous populations, the Shipibo are generally distrustful of outsiders. 
Following in-depth consultations with local leaders and governmental health 
institutes, the protocol for sampling within this traditional Amazonian community 
was introduced to the community and volunteer participants consented to 
involvement upon deposition of fecal samples (Obregon-Tito et al., 2015). 






The remoteness of the communities	is one of the reasons their unique culture 
has survived with little outside influence. The community members maintain their 
cultural identity and for the most part live like the many generations before them, 
relying mainly on subsistence strategies including hunting and fishing. There is a 
strong seasonal difference in nutrition and health as subsistence strategies greatly 
vary with the seasonal changes. Each participant self-identified as a permanent 
member of the community and furthermore, identified all four grandparents as 
permanent members of the community. All participants completed a detailed diet, 
health and medical history questionnaires during public, community engagement 
meetings.  Although rare, participants medically treated outside of the community or 
those that recently travelled outside of the community were excluded for this study.  
None of the participants presented here had been treated for any illness requiring 
therapeutic antibiotics (Obregon-Tito et al., 2015).     
 
Enrichment and cultivation 
	
Freshly voided fecal material was collected and processed anaerobically on 
site prior to being transported on ice to the University of Oklahoma, Norman, 
Oklahoma for further processing.  Solid material from each sample was stored in 
three ways (i) swabs were used to collect fecal material then added to pre-reduced, 
sterile transport media, (ii) solid material was added directly to microcentrifuge tubes 




anaerobic jar and remained on ice or were refrigerated until arrival at the Lawson 
Microbial Systematics Laboratory.  
 
Isolation and identification 
	
Anaerobic enrichments for the cultivation and isolation of dominant members 
of the gastrointestinal tract were prepared based on their individual growth 
requirements and inoculated with 1 ml of fecal slurry.   Media enrichments included 
liquid and solid MRS (Difco), Brucella (Difco), Brain Heart Infusion (BD), 
Schaedler medium (Remel), Columbia medium (BD), Fastidious Anaerobic Agar 
(Oxoid) and Cooked Meat Medium (BD). Media were additionally supplemented 
with 5% defibrinated blood, rumen fluid, vitamin K, hemin or horse serum. Strains 
were isolated from enrichments using the roll tube method, dilution to extinction, 
and repeated sub-cultivation on solid agar.  DNA of strains was extracted and 
identified by 16S rRNA gene sequencing as described below in DNA extraction and 
phylogenetic analysis section. While a number of strains were identified from the 
enrichments as those previously described members belonging to dominant phyla of 
the gastrointestinal microbiome, the focus of this chapter is a previously 







Strain NE08VT was isolated from an enrichment (modified MRS) that 
contained (per Liter): casein peptone, tryptic digest 10 g, meat extract 10 g, yeast 
extract 5 g, glucose 20 g, Tween 80 1 g, potassium phosphate 2 g, sodium acetate 5 
g, ammonium citrate 2 g, magnesium sulfate 0.2 g, manganese sulfate 0.05 g with 20 
% ethanol and 0.1 % hemin solution, pH 6.5.  Enrichments were incubated under an 
anaerobic gas mix of 85 % nitrogen, 10 % carbon dioxide, and 5 % hydrogen at 
37°C. After incubation for 7 days, serial dilution and repeated sub-culturing onto 
fresh modified MRS agar was performed until pure colonies were obtained. The 
strain was then transferred to and maintained on Brucella (BD/BBL) agar 
supplemented with 5 % defibrinated blood. 
 
Phenotypic and biochemical characterization 
	
For morphological observations, strain NE08VT was grown on Brucella 
(BD/BBL) agar supplemented with 5 % defibrinated blood at 37°C for 48 h.  Cell 
characterized with an Olympus CX41 light microscope. The pH range, temperature 
range and salinity range were determined using peptone-yeast extract (PY) broth 
(DSMZ 104 medium). The pH range for growth was assessed over the range of pH 
5.0-9.0 (increments of 0.5 pH units) using sodium citrate buffer for pH 5.0-6.0, 
potassium phosphate buffer for pH 6.0-8.0, and Tris buffer for pH 8.0-9.0.  The 
salinity range for growth was tested with NaCl concentrations of 0 - 9% (w/v).  The 




30, 37, 43, 47, and 60 °C.  Optimum growth conditions were determined by 
monitoring the optical density using a spectrophotometer at 600 nm (Spectronic 20D, 
Milton Roy). Additional biochemical characterization was determined using the 
Rapid ID32A system (bioMeriux) and all reactions were performed in duplicate. 
Metabolic characterization was performed by use of the BIOLOG system (BIOLOG, 
Hayward, California) following the supplied manufacturer’s instructions. Briefly, 
strain NE08VT was cultivated on BUATM agar supplemented with 5 % defibrinated 
blood for 48 hrs and used to inoculate an AN MicroPlateTM. The AN MicroPlateTM 
was incubated at 37oC under anaerobic conditions for 72 hr. All test were performed 
in duplicate.  
Metabolic end products were determined from cultures grown under 
anaerobic conditions in PYG broth. Sample analyses were carried out in duplicate on 
an Aminex HPX-87H organic acid analysis column (Bio-Rad), using ion-exclusion 
HPLC with 0.015 HCl running buffer at a flow rate of 0.9 mL/min.  Retention times 
and peak areas of fermentation products were compared to standards of acetate, 
butyrate, lactate, succinate, formate, and propionate. 
 
DNA extraction and phylogenetic analysis 
For phylogenetic analysis, DNA of strain NE08VT was extracted using the 
UltraClean® Microbial DNA Isolation Kit (MoBio Laboratories, Inc.) following 




using universal primers 8f (positions 8 to 28, Escherichia coli numbering) and pH* 
(1542 to 1522) (Hutson et al., 1993). The amplicon was purified using Exo-SapIt 
(USB Corporation) to remove unincorported primers and dNTPs and the sequence 
determined. The closest known relatives of strain NE08VT based on the 16S rRNA 
gene sequence were determined by performing database searches using the program 
EzBioCloud's Identify (https://www.ezbiocloud.net/) (Kim et al., 2012, Yoon et al., 
2016). These sequences and those of other related strains were aligned with the 
sequence derived from NE08VT using the program ClustalX. Phylogenetic 
reconstructions were performed in MEGA (version 4) (Tamura et al., 2011) using 
the neighbour-joining method (Saitou & Nei, 1987), applying evolutionary genetic 





Analysis of fatty acids and mol% G+C content was performed under 
conditions chosen to directly compare strain NE08VT with its closest relative, C. 
vulturis. Biomass for fatty acid analysis was collected from Brucella (BD/BBL) agar 
supplemented with 5% defibrinated blood at 37°C for 48 h. Fatty acid methyl esters 
were extracted from isolated colonies using the Sherlock Microbial Identification 
System (MIDI) version 6.1 as described previously (Sasser, 1990, Kämpfer & 
Kroppenstedt, 1996). Analysis was performed using an Agilent Technologies 6890N 




column (HP-2 25m x 0.2 mm x 0.33 µm film thickness) and a flame ionization 
detector with hydrogen used as the carrier gas. The temperature program was 
initiated at 170°C and increased at 5°C min-1 reaching a final temperature of 270°C. 
Fatty acids were identified and expressed in the form of percentages using the QBA1 
peak naming database. The mol% G+C was determined according to the method of 
Mesbah et al. (Mesbah et al., 2011). 
	
Antimicrobial susceptibility testing 
 
All antimicrobial susceptibility testing was performed according to the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
(https://mic.eucast.org/Eucast2/) and the Clinical and Laboratory Standards Institute 
and International Organization for Standardization (ISO) guidelines 
(https://clsi.org/standards/products/iso-documents/). Stock solutions were prepared 
for 15 antibiotics and filter sterilized. These compounds included β-lactams 
(ampicillin, carbenicillin, cefaclor, and ceftriaxone), aminoglycosides (gentamycin 
and kanamycin), tetracyclines (doxycycline, oxycycline and tetracycline), quinolones 
(ciprofloxacin and nalidixic acid), macrolides (erythromycin), lincosamides 
(clindamycin), glycopeptides (vancomycin), and chloramphenicol. Working 
solutions were created in Mueller Hinton (MH) broth from each stock solution 
according to EUCAST break points and the upper limit growth (Table 15).  
The range of concentrations were selected based on similar reference strains 
in EUCAST database, when available (https://mic.eucast.org/Eucast2/). The range 




antibiotic solution was dispensed into 96-well plates at 50 µl per well. An inoculum 
was prepared in anaerobic MH broth from colonies grown on BHI + 5% blood from 
24 hour growth at 37°C at a turbidity equivalent to a 0.5 McFarland standard. To 
each antibiotic solution, 50 µl of inoculum was added for a final volume of 100 µl 
/well. Each antibiotic solution was tested in triplicate.  
The 96-well plates were incubated for 24 hours at 37°C under anaerobic 
conditions. Each antibiotic was tested in triplicate for all concentrations. When not in 
agreement, the isolate was retested. All plates were graded by visual confirmation of 
growth, without strain information attached to each plate to reduce biases. Results 
were determined and compared to EUCAST breakpoints.  
A volume of 100 µl inoculum was added to the wells without antibiotic 
solution and an aliquot was plated onto BHI + 5% blood agar after incubation of 96-
well plates to ensure purity. Sterility of uninoculated antibiotic solution wells were 
verified after incubation. Each well was compared to the growth control to determine 
MIC.  
 
Whole genome sequencing and assembly 
	
Whole genome sequencing (WGS) was employed to determine functional 
properties present in the genome and other phylogenetic relationships to close 
relatives. The genome of strain NE08VT was sequenced using an Illumina MiSeq 
sequencing platform (Illumina, CA). Library preparation, sequencing, and runs were 




construction was performed by the Laboratories of Molecular Anthropology and 










As strain NE08VT is the only representative of the species, the closest 
relatives based on 16S rRNA gene sequence similarity were selected for comparison 
of antibiotic resistance gene (ARG) determinants. C. sulfidigenes strain 113A, C. 
senegalense strain JC122T, C. argentinense strain CDC 2741 and Clostridium cluster 
I type species C. butyricum strains KNUL09 and CDC 51208 were chosen as both 
clinical and non-clinical representatives. All genomes were downloaded from 
National Center for Biotechnology Information (NCBI).  Average Nucleotide 
Identities (ANI) of NE08VT and related taxa were calculated using the OrthoANIu 





Genomes of the Clostridium species were investigated for the presence of 
ARGs using the Comprehensive Antibiotic Resistance Database (CARD) (version 
1.1.8) (McArthur et al., 2013, Jia et al., 2017).  The assembled genomes were 
annotated using Prokaa version 1.12 (beta) (Seemann, 2014), output files were 
analyzed using the Resistance Gene Identifier (version 3.2.0) to predict resistance 
genes based on homology and single-nucleotide polymorphism (SNP) models.  
Additionally, results were verified by standard BLASTP search against the CARD 




≥60% similarity to the reference sequences were included as a cutoff as AR genes	
<60% could be the result of novel genes or significant divergence from known 
mechanisms available in the database that CARD is able to recognize. This cut-off 
restricts the detection of more distant homologs and ensures the detected variant is 
likely a functional AR gene.  The resistance gene analysis of the clostridial genomes 
was then compared between strains. Predicted AR proteins occurring in multiple 
species were aligned with one another and with the CARD reference sequences.  
Additional sequence similarity of the aligned resistance proteins was calculated 
using Clustal X and GeneDoc. The results of the predicted AR proteins were 





Phenotypic and biochemical characterization 
	
NE08VT was determined to be a Gram-stain positive, strictly anaerobic, 
spore-forming and non-hemolytic rod-shaped bacterium. Cells occurred as single 
cells or in pairs.  Subterminal to terminal spores were observed. Colonies grown on 
Brucella (BD/BBL) agar supplemented with 5 % defibrinated blood at 37°C for 48 h 
were observed to be yellow brown in color, irregular with undulate margins.  
Oxidase and catalase activities were not observed. The pH and temperature ranges 
for growth were pH 5.0 - pH 9.0 and 30 - 47 °C with optimal growth at pH 7.0 and 
temperature 37 °C.  The strain grew well in NaCl concentrations between 0-3 % 
(w/v).  The main fermentation end-products detected from PYG media were acetate 
and butyrate.  Positive reactions of the AN MicroPlateTM indicate the organism’s 
ability to utilize L-fucose, palatinose, L-rhamnose, L-glutamine, and L-serine as sole 
carbon sources.  
Using the API Rapid ID 32A system positive reaction were obtained with 
arginine dehydrogenase, alkaline phosphatase, arginine arylamidase, glycine 
arylamidase, histidine arylamidase, leucine arylamidase, leucyl glycine arylamidase, 
mannose, and pyroglutamic acid arylamidase.  No activity was observed for urease, 
α-galactosidase, β-galactosidase, β-galactosidase-6 phosphate, α-gucosidase, α-
arabinosidase- β-glucuronidase, N-acetyl- β-glucosidase, raffinose, proline 
arylamidase, phenyl arylmidase, tyrosine arylamidase, alanine arylamidase, glutamic 




Morphological, physiological and biochemical properties are provided in the species 




 Phylogenetic analysis demonstrated that the organism was a member of the 
Firmicutes sharing a relationship with members of the genus Clostridium sensu 
stricto, also recognized as Clostridium rRNA group I (Collins et al., 1994, Wiegel et 
al., 2006) (Fig 9).  The pairwise comparisons of trimmed sequences showed that 
strain NE08VT was most closely related to C. vulturis (97.4% 16S rRNA sequence 
similarity) with the two organisms forming a cluster in the phylogenetic tree.  A 
number of organisms demonstrated lower sequence similarity values revealing a 
more loose relationship; these included C. senegalense, C. subterminale, C. 
argentinense, C. thiosulfatireducens, C. sulfidigenes, C. schirmacherense, C. 
punense and C. huakuii   (Table 17). All the major groupings in the neighbor-joining 











Figure 9. Phylogenetic tree showing the relationship of NE08VTto the most closely 
related species within Clostridium sensu stricto and other representative members of 
the Clostridiaceae.  The tree was constructed using the neighbor-joining method 
based on the pairwise comparison of approximately 1,370 nucleotides. 
Faecalibacterium prausnitzii was used as the outgroup. Bootstrap values (>90%), 






















Faecalibacterium prausnitzii ATCC 27768T (AJ413954)
Caloramator fervidus ATCC 43204T (LO9187)
Fonticella tunisiensis DSM 24455T (HE604099)
Youngiibacter fragilis DSM 24749T (JF262039)
Proteiniclasticum ruminis JCM 14817T (DQ852338)
Hathewaya histolytica ATCC 19401T (M59094)
Haloimpatiens lingqiaonensis JCM 19210T (KC869664)
Clostridium butyricum DSM 10702T (AQQF01000149)
Clostridium bowmanii DSM 14206T (AJ506120)
Clostridium aurantibutyricum DSM 793T (LZYW01000149)
Clostridium guangxiense ZGM211T  (KT000268)
Clostridium neuense BCRC 80949T (KT824779)
Clostridium psychrophilum DSM 14207T (AJ297443)
Clostridium acidisoli DSM 12555T (AJ237756)
Clostridium pascui DSM 10365T (X96736)
Clostridium aciditolerans DSM 17425T (DQ114945)
Clostridium peptidivorans DSM 12505T (AF156796)
Clostridium liquoris DSM 100320T (KC331197)
Clostridium lundense DSM 17049T (AY858804)
Clostridium tetanomorphum DSM 4474T (DQ241819 )
Clostridium vulturis YMB-57T (JQ423949)
Clostridium amazonense sp. nov. NE08VT (KP281434)
Clostridium senegalense JC122T (JF824801)
Clostridium thiosulfatireducens DSM 13105T (AY024332)
Clostridium subterminale DSM 6970T (AF241844)
Clostridium punense DSM 28650T (JN093128)
Clostridium huakuii LAM 1030T (KC967412)
Clostridium argentinense ATCC 27322T (X68316)
Clostidium schirmacherense  DSM 17394T (AM114453)
Clostridium frigoris DSM 14204T (AJ506116)
Clostridium malenominatum DSM 1127T (FR749893)
Clostridiumm algoriphilum DSM 16153T (AY117755)
Clostridium lacusfryxellense DSM 14205T (AJ506118)
Clostridium estertheticum DSM 8809T (S46734)
Clostridium tagluense DSM 17763T (DQ296031)
Clostridium beijerinckii DSM 6422T (CP000721)
Clostridium acetobutylicum ATCC 824T (AE001437)









Table 17. Comparison of strain NE08VT to closely related species. 
 
  
 Although no precise correlation exists between % 16S rRNA sequence 
divergence and species delineation, for many years 3% divergence values were 
generally considered adequate for the separation of species (Stackebrandt & Goebel, 
1994). However, studies by Stackebrandt and Ebers demonstrated that this value 
could be lowered to 1.3% (Stackebrandt & Ebers, 2006). Their exhaustive 
investigation determined that where 16S sequence similarities values of 98.7% and 
below were obtained between strains, DNA-DNA hybridizations could be omitted 
without a risk for incorrect species differentiation (Meier-Kolthoff et al., 2013). This 
cutoff of 98.7% was verified by Kim et al. (2014) for differentiating two species. 
Similarly, the cutoff value of <94-95% 16S sequence similarity is now routinely used 
in the delineation of genera when considered in tandem with appropriate phenotypic 
and chemotaxonomic information. 
 
Strain Similarity 16S rRNA gene sequence similarity 
Length of 
sequence (bp) 
C. amazonense - 1423  
C. vulturis 97.4% 1409 
C. senegalense 96.9% 1432 
C. subterminale 95.5% 1431 
C. argentinense 95.3% 1432 
C. thiosulfatireducens 95.2% 1431 
C. schirmacherense 95.1% 1431 
C. sulfidigenes 95.1% 1430 
C. punense 95.0% 1429 




The draft genome assembly of strain NE08VT consisted of 447 contigs and 
4,409,344 bp.  Genome analysis using the CARD database revealed genes coding for 
resistance to the antibiotics vancomycin, elfamycin, rifampicin, kirromycin and 
isoniazid. A summary of the sequencing statistics for the related Clostridium strains 
can be found in Table 18. The genomes ranged in G+C ratio from 26.9% (C. 
senegalense) to 30.0% (C. sulfigenes). Average aligned length of the Clostridium 
genomes to strain NE08VT is shown in Table 19. ANI analysis of draft genomes of 
most closely related Clostridium species based on 16S rRNA sequence similarity (C. 
vulturis, C. senegalense, and C. subterminale) was not calculated due to lack of 
available genomes. The ANI analysis of strain NE08VT with the genomes of closely 
relates species revealed a similarity index with C. argentinense CDC 2741 of 75.2% 
of 880,713 aligned base pairs. 
 
Table 18. Clostridium species genome summary 
Strain Contigs Total length (bp) GC ratio 
Strain NE08VT 447 4,409,344 27.0% 
C. argentinense 2 4,803,058 28.8% 
Strain CDC 2741 
C. sulfidigenes 96 3,717,420 30.0% 
Strain 113A 
C. senegalense 83 3,925,888 26.9% 
Strain JC112 
C. butyricum 2 4,627,894 28.7% 
Strain KNULO9 
C. butyricum 










The cellular fatty acid profile of strain NE08VT determined that the 
predominant fatty (10 % of total fatty acids or higher) were C13:0 anteiso (19.7%), 
and C16:0 (26.4%) with lower amounts of C16:1 w9c   (5.6%), C14:0 (6.0%), and C18:1 ω9c 
(8.2%) (Table 6). The profile differs significantly from C. vulturis in that this 
organism does not produce C13:0 anteiso but produces major amounts of C18:1 ω9c in 
comparison to strain NE08VT. C. vulturis also produces C18:1 ω9c DMA  which  strain 
NE08VT does not (Paek et al., 2014). The lack of C18:1 w9c DMA in strain NE08VT 
appears to be an important differential characteristic with other members of this 
loose group of organisms that includes C. vulturis, C. subterminale, C. sulfidigenes 
and C. thiosulfatireducens all of which synthesize this particular fatty acid (Table 





Strain similarity OrthoANIu value Average aligned length (bp) 
C. argentinense 75.2% 880,713 Strain CDC 2741 
C. sulfidigenes 72.8 % 703,087 Strain 113A 
C. senegalense 77.1% 1,216,165 
Strain JC 112 
C. butyricum 71.1% 440,104 
Strain KNUL09 
C. butyricum 





Table 20.  Fatty acid composition of NE08VT and its closest relative C. vulturis 
_Predominant products are shown in bold, products that represented <1.0 %  were 
omitted; cyclo, cyclopropane; DMA, dimethylacetal 
Fatty Acids 1 2 
C12:0 1.9 - 
C13:0 anteiso 19.7 - 
C14:0 6.0 2.4 
C15:0 anteiso 1.3 - 
C15:1 w8c 4.6 - 
C16:0 26.4 31.9 
C16:0 iso 1.9 - 
C16:1 w9c 5.6 - 
C16:1 w5c 1.2 - 
C17:0 - 1.4 
C17:1 w8c 1.7 - 
C17:1 w9c 1.7 - 
C18:0 - 8.7 
C18:1 w9c 8.2 27.0 
C18:1 t 11 - 2.5 
C18:2 w9,12c - 3.1 
C18:0 DMA - 1.1 
C18:1 w9c DMA - 10.3 
C19:0 cyclo 9, 10/:1 - 1.6 
C19:0 cyclo 9, 10 DMA - 1.2 
Summed feature 3 3.9 - 
Unknown 14.969 2.4 - 




Determination of breakpoints 
	
Few cultured Clostridium spp. are included in the EUCAST database and 
there are no genus specific breakpoints. When available, Gram-positive anaerobe 
breakpoints were used (Table 21). All other breakpoints are non-species specific and 
incorporate the EUCAST pharmacokinetic (drug concentration over time) and 
pharmacodynamics (drug effect over time) (PK/PD) indices as previously reported 
(Mouton et al., 2012). Breakpoints and results of susceptibility testing are reported in 
Table 21.  
The MIC for strain NE08VT was determined to be resistant for all antibiotics. 
The organism was not expected to have such high levels of resistance across all 
classes of antibiotics, especially as the community from which the organism was 
isolated has not been exposed to the selective pressures normally associated with 
antibiotic treatment.  While ARG are naturally occurring and expected to be present 
to some degree within gastrointestinal communities, resistance to concentrations at 
this level are especially concerning. These organisms may	act as a reservoir of 
resistance determinants that can be mobilized throughout the gastrointestinal 
microbial community. Further analysis of ARG of closely related species and related 
taxa of clinical significance should be performed. Unfortunately, no additional 
strains from this traditional community are available for analysis. However, the 
ability of ARG to be established and maintained within such remote communities 




between taxa may serve as an indicator of how they are spread and how the genes 









The CARD was chosen because it is one of the most continuously updated, 
comprehensive resources. The CARD is a curated collection of antimicrobial 
resistance gene and mutation sequences that uses the Resistance Gene Identifier 
(RGI) software (https://card.mcmaster.ca/analyze/rgi) for the detection of AR in 
protein sequences. The CARD then catalogs resistance predictions by drug class and 
resistance mechanisms. Sequences are analyzed under three paradigms – Perfect, 
Strict and Loose (a.k.a. Discovery). Perfect classification detects perfect matches to 
the curated reference sequences and mutations in CARD, Strict classification detects 
previously unknown variants of known ARGs with curated similarity cut-offs to 
ensure the variant is most likely a functional ARG and Loose classification predicts 
potentially new ARG and catalogs homologous sequences that may not have a role in 
AR. All of the reported ARG for Clostridium strains were classified as Strict protein 
variants. The resistance gene % sequence similarity of detected resistance genes and 
CARD reference genes is summarized in Tables 22 and 23.  A total of 29 resistance 
genes were detected between the six clostridial genomes. The summary of antibiotic 
resistance ontology (ARO) accession number, antibiotic class resistance, resistance 
mechanisms and the organism of which the reference sequence was curated are 
displayed in Table 24. Of these 29 genes 22 were detected within the C. argentinense 
genome. Multiple tetracycline resistance determinants, including ribosomal 
protection proteins (tetM, tetB(P) and tetO) and an efflux protein tetA(P), and six 




the C. argentinense genome.  Strain NE08V T shared two ARGs in common with C. 
argentinense (SarpoB and ScEFTu). Both genes shared 91% sequence similarity 
with C. argentinense ARGs. These shared a lower percent similarity to database 
references than when compared to other resistant gene variants from within 
Clostridium sensu stricto, but are of interest in the future as they were detected 
within organisms of clinical significance. Strain NE08VT contained only 6 genes 
SarpoB, ScEFTu, EcEFTu, MTkatG, vanRG and vanRI that confer resistance 
rifampicin, elfamycins, isoniazid and vancomycin respectively. Interestingly, two 
genes, ECEFtu and MTkatG, were found exclusively in strain NE08VT. The high 
level of resistance is not determined by the detected genes, suggesting additional 
resistance genes not detected here, or potential novel resistance mechanisms. A 
further investigation of this organism and the resistome is necessary in order to 
identify these determinants. Excluding some ARGs of C. argentinense, lower % 
similarity was detected from the CARD reference genes than those determined 
between the clostridial variants. This could be due to the variants originating from 
distantly related genomes, and highlights the need to include more resistant 
determinants from other taxa. The two genes shared between all clostridial species 
but strain NE08VT (SarpoB and SagyrB), shared a higher % sequence similarity 















Table 25. Clostridium strains % similarity of shared SarpoB resistance genes 
SarpoB NE08VT C. argentinense1 C. butyricum2 C. butyricum3 
NE08VT - - - - 
C. argentinense1 91% - - - 
C. butyricum2 82% 81% - - 
C. butyricum3 82% 82% 99% - 
CARD4 64% 64% 64% 64% 
1, Strain CDC 2741;2, Strain KNULO9; 3, strain CDC 51208; 4, CARD comparison strain from S. 
aureus 
	
Table 26. Clostridium strains similarity of shared SarpoB resistance genes 







1187 91% 82% 82% 64% 
0 96% 91% 91% 78% 
0 0 0 0 2% 
C. 
argentinense1 
1085 1187 81% 82% 64% 
1146 0 91% 91% 78% 
0 0 0 0 2% 
C. butyricum2 
984 973 1186 99% 64% 
1091 1091 0 100% 79% 
1 1 0 0 2% 
C. butyricum3 
985 974 1177 1186 64% 
1091 1091 1186 0 79% 
1 1 0 0 2% 
CARD4 
768 774 771 769 1172 
942 942 951 951 0 
33 33 32 32 0 












Description of Clostridium amazonense sp. nov.  
 
Clostridium amazonense (am.a.zon,en'se.) N.L. neut. adj. amazonense 
pertaining to the community from where the organism was first isolated. Cells are 
Gram-positive obligately anaerobic rods occurring as single cells or in pairs. Spores 
are formed and located either subterminally or terminally. When grown 
anaerobically on Brucella blood agar for 48 h, colonies are irregular, 1 mm in 
diameter with undulate margins and have a yellow brown color. Catalase and oxidase 
negative. Optimal growth temperature is 37°C, and growth occurs between 30-47°C.  
Growth is supported at pH 5.5-9.0, and is optimal at pH 7.0.  Growth occurs in the 
presence of 0-3% (w/v) NaCl. Using the ID 32A system, positive reactions are 
obtained for arginine dehydrogenase, alkaline phosphatase, arginine arylamidase, 
glycine arylamidase, histidine arylamidase, leucine arylamidase, leucyl glycine 
arylamidase, mannose, and pyroglutamic acid arylamidase.  Negative reactions are 
obtained for α-galactosidase, β-galactosidase, β-galactosidase-6 phosphate, α-
gucosidase, α-arabinosidase- β-glucuronidase, N-acetyl- β-glucosidase, raffinose, 
proline arylamidase, phenyl arylmidase, tyrosine arylamidase, alanine arylamidase, 
glutamic acid decarboxylase, α-fucosidase, glutamyl glutamic acid and serine 
arylamidase. The main fermentation end products from PYG medium were acetate 
and butyrate.  Antimicrobial susceptibility testing revealed the strain was likely 
resistant to β-lactams (ampicillin, carbenicillin, cefaclor, and ceftriaxone), 
aminoglycosides (gentamycin and kanamycin), tetracyclines (doxycycline, 




macrolides (erythromycin), lincosamides (clindamycin), glycopeptides 
(vancomycin), and chloramphenicol. Six resistance gene variants were determined 
corresponding to vancomycin, elfamycin, rifampicin, kirromycin and isoniazid. The 
major fatty acids (>10%) are C13:0 anteiso and C16:0. The DNA G + C content of the 
type strain is 30.5 mol%.  The type strain is NE08VT (=DSM 23598T  = CCUG 
59712T) is isolated from a fecal sample of an individual in the province 
of Loreto, Peru.  The 16S rRNA gene sequence for strain NE08VT was deposited 
with the GenBank Sequence Database under the following accession number 
KP281434.
Discussion 
In addition to its unique 16S rRNA gene sequence, strain NE08VT was found 
to possess biochemical and chemotaxonomic traits consistent with organisms 
belonging to members of the genus Clostridium but could clearly be distinguished 
from its nearest phylogenetic relatives using characteristics shown in Tables 2 and 3. 
Although there is much discussion on the validity of describing novel genera and 
species on a single strain, this continues to be a common practice and allows further 
strains or related species to be identified in subsequent studies by other researchers.  
As the number of publically available genomes continues to increase, there is 
a need to critically evaluate the relatedness between strains in order to resolve 
phylogeny and correctly assign these strains to the correct taxa. The DNA-DNA 
method (DDH) has been regarded as the gold standard (despite evidence that it is 




nstrate the relatedness between strains as an indirect measure of sequence 
similarity (Rosselló-Móra & Amann, 2015). The species boundary DDH value of 
70% equates to ANI values of 95-96%. Similarly, the ANI value of 96% corresponds 
with the 16S rRNA sequence similarity of 98.65% (Kim et al., 2014).  
Taxonomic revisions to the classification of  Clostridium sensu stricto 
continue to reassign misclassified species to other taxa based on 16S rRNA 
sequences (Yutin & Galperin, 2013, Lawson & Rainey, 2016). While the state of 
classification of the genus Clostridium and related taxa is far from perfect, recent 
concerted efforts have led to the taxonomy of Clostridium sensu stricto being 
improved upon (Gupta & Gao, 2009, Vos et al., 2011).  In addition to the 16S rRNA 
analysis, additional molecular markers have been identified that appear to be 
conserved in Clostridium cluster I and suggest that the genus is phylogenetically 
distinct from other phylogenetic groups within the clostridia (Gupta & Gao, 2009).   
At the time of publication >100 species are assigned to Clostridium sensu 
stricto (http://www.bacterio.net/clostridium.html). WGS prediction of an organism’s 
phenotype may aid in differentiation between organisms, but at present should be 
combined in a polyphasic approach. Large, independent studies have yet to 
accurately demonstrate that the estimated >37,000 available bacterial genomes 
provide precise phenotypic predictions in studies of specific organisms (Fournier et 
al., 2015).  
Contributions to EUCAST (antibiotic break point information, addition to 




selection) and CARD (novel, non-clinical strains and non-Western strains for 
comparison to clinical strains and strains with industrial biases, potential detection of 
novel genes) from this study are especially important at present as the widespread 
antibiotic resistance in bacterial populations is particularly troubling. As more strains 
and resistant determinants are added to CARD this issue will likely be resolved. 
With continued curation of resistance genotypes, the accurate prediction of resistance 
phenotypes has the potential to become a valuable tool for the surveillance of 
emerging and established pathogens.  
Furthermore, the increasing number of cultured strains recovered from 
individuals from indigenous communities will augment the insights gained from the 
molecular tools commonly used in these studies. Studies of hunter-gatherers 
maintaining traditional dietary practices are a powerful resource for our 
understanding of the ancestral state of the human microbiome and provide a 
foundation for understanding how the human microbiome responds to urbanism and 
Westernization. Though the exact role of NE08VT in the gastrointestinal tract 
remains unclear, this study confirmed that the complex ecosystem within the 
gastrointestinal microbiome of remote, indigenous Peruvian communities harbors 
novel bacterial species previously not identified within Western, urbanized 
populations.  Loss of key microbial species within urbanized populations compared 
to traditional indigenous communities is an area of increased scientific interest and 
studies like the one reported here are essential for developing our understanding of 




Ultimately, the identification and characterization of novel gastrointestinal species 
will allow us to form a clearer picture of the interrelationships between organisms 
that constitute this ecosystem and better understand their role in human health and 
disease. The characterization and molecular insights of novel human associated 
microbes from these indigenous communities may aid in shaping our understanding 
of the human microbiome and the antibiotic resistome, and direct the development of 



















Insights into the antibiotic resistome of a traditional indigenous 
Peruvian community from cultivated representatives of Bacillaceae, 





Presented here are the results of an initial screening and subsequent susceptibility 
testing and determination of resistance genes by whole genome sequencing of a 
number of organisms isolated from a remote, traditional indigenous Peruvian 
community. Following the initial resistance screen, bacterial strains were identified 
and resistance genes were determined using a curated resistance database. Resistant 
organisms were found to contain resistance genes for all classes of antibiotics tested. 
The community has had limited or no exposure to modern therapeutic antibiotics and 
therefore represents an ideal cohort in which to work with to determine if wide 
spread resistance is a modern phenomenon linked to human overuse and abuse of 
antibiotics or a natural phenomenon of the ancient and pervasive spread of 









In the past several decades, the rise and spread of antibiotic resistance has 
become alarming and has led to a worldwide health concern (World Health 
Organization, 2014).  Antibiotic resistance has become a threat to the effective 
treatment of a growing number of bacteria, especially among those bacteria 
responsible for common health-care associated infections. In a recent report, the 
United States Center for Disease Control and Prevention gave a conservative 
estimate of 2 million illnesses and over 20,000 deaths directly caused by antibiotic 
resistant bacteria each year (Centers for Diseae Control & Prevention, 2013).  In 
addition to health concerns, the costs of bacterial infections total over $23 billion in 
societal and healthcare costs annually in the United States. Resistant pathogens lead 
to higher health care costs because they often require more expensive drugs and 
extended hospital stays. 
The recent increase and spread of antibiotic resistant bacteria is most often 
attributed to the overuse via over prescription and misuse of antibiotics in clinical, 
agricultural, and veterinary practices as therapeutic agents, growth promoters and as 
prophylactics (Levy & Marshall, 2004, Cabello, 2006, Koike et al., 2007, Manuzon 
et al., 2007, Forslund et al., 2013, Spellberg et al., 2013). The hypothesis that these 
selective pressures provide drivers for antibiotic resistance is consistent with studies 
that have demonstrated that when a microbial community lack such selective 
pressures, antibiotic resistance genes (ARG) were absent (Österblad et al., 2001, 




multidrug resistance from isolated, natural habitats such as isolated cave systems, 
Alaskan soils and glacier environments (Allen et al., 2009, Bhullar et al., 2012, 
Segawa et al., 2013). In this context, we sought to examine the prevalence of 
antibiotic resistance genes and the minimum inhibitory concentration of a panel of 
antibiotics of strains cultured from the gastrointestinal microbiome of an isolated, 
traditional indigenous Peruvian community with limited or no exposure to modern 
therapeutic antibiotics. Working with such groups will contribute to our 
understanding of how wide spread ARGs are and how insights into how the genetic 
diversity of the resistant determinants has developed. The high level of diversity and 
global distribution of resistance genes is of particular concern as antimicrobial 
resistance (AMR) mechanisms have been reported for all known antibacterial drugs 
that are currently available for clinical use in both human and veterinary medicine 
(World Health Organization, 2014). Understanding the origin of ARGs and the 
mechanisms of emergence, prevalence, and their evolution over time is fundamental 
in our efforts to prevent, manage, and ultimately the potential to predict genes of 
concern.   
Antibiotic resistance can be due to innate susceptibility, intrinsic resistance, 
or acquired resistance (D’Costa et al., 2011). Even in the absence of previous or 
ongoing antibiotic treatment, antibiotic resistance genes from other sources can 
establish within the body’s commensal microbiome (Arason et al., 1996, Lancaster 
et al., 2003, Bartoloni et al., 2004, Jernberg et al., 2010). The term “Antibiotic 




within a microbial soil community.  The resistome serves as a reservoir of resistance 
determinants that can be mobilized into the microbial community (D'Costa et al., 
2006). Resistome machinery likely originated from within soil communities as 
antibiotic producing strains possess self-immunity and eventually transferred this 
property to animal and human pathogens (D’Costa et al., 2011, Nesme & Simonet, 
2015). Soil communities are one of the richest habitats in terms of microbial 
diversity and contain most of the known bacterial producers of antibiotic molecules. 
Furthermore these producers contain ARGs identical to those found in clinical 
samples (Nesme & Simonet, 2015). 
Another likely reservoir is the human gastrointestinal tract, that essentially is 
a vessel facilitating the exchange of genetic material between the enormous number 
of microorganisms that play a vital role in health and disease processes. The 
interactions between host and the diverse gastrointestinal microbial communities aid 
in nutrition, development of the immune system and protection against pathogens 
(Xu & Gordon, 2003, Cho & Blaser, 2012). In addition to playing these roles in host 
health and development, the gastrointestinal microbiome may serve as a reservoir of 
ARGs accessible to commensal and pathogenic organism (Wang et al., 2006, 
Sommer et al., 2009, Penders et al., 2013, Rolain, 2013). In an investigation into the 
role of the human gastrointestinal microbiome as a reservoir of resistance, Sommer 
et al. (2009) determined that most of the resistance genes identified from using 
culture-independent sampling, had not been previously identified. Furthermore, these 




when cloned into host cells. In contrast, nearly half of the resistance genes identified 
in cultured isolates were identical to resistance genes of major pathogens (Sommer et 
al., 2009).   
Ongoing investigations of the ancestral state of the gastrointestinal 
microbiome may aid in expanding our knowledge of how modern, cosmopolitan 
biases have impacted the relationships between host animals and microbes and serve 
in determining the role of the gut microbiome as a reservoir for resistance and 
possible origin of resistance genes. Efforts by collaborators have determined that the 
ancestral microbiome is more similar to traditional communities than cosmopolitan 
populations (Tito et al., 2012, Obregon-Tito et al., 2015).  Novel taxa, atypical of 
cosmopolitan groups were reported from previous investigations of traditional 
communities (O'Neal et al., 2015, Patel et al., 2015). Given that these communities 
harbor unique microbial communities and novel taxa, I hypothesized that such 
groups may be host to a distinct antibiotic resistome, and may contain novel 
resistance mechanisms in addition to those previously identified in the microbial 
communities encountered in industrialized nations.  
Here, data is presented from San Mateo, a traditional, hunter-gatherer group 
residing along the Galves River deep within the Amazonian jungle of Peru (Fig 1) 
(this is a different community than investigated in previous chapter).  This Matses 
community is geographically remote and has maintained a traditional lifestyle with 
little contact with outside groups. A recent investigation determined that the 




diversity when compared to industrialized nations (Obregon-Tito et al., 2015). Gut 
microbiome of indigenous populations may provide insights into the spread and 




Materials and Methods 
 
Sampling from San Mateo 
	
The community of San Mateo is composed of 14 hunter-gatherer families 
residing within the Matses National Reserve, along the Peruvian-Bolivian border 
(Fig 10).  A total of 25 participants between the ages of 2 and 52 volunteered to 
participate in the study.  This study was conducted in collaboration with the Matses 
as previously described in Obregon-Tito et al. (2015).  Briefly, members have been 
geographically, historically and socially isolated and are traditional hunter-gatherers. 
Before sampling, community meetings and parasite screening were offered to all 
community members. All participants filled out detailed diet, health and medical 
history questionnaires. Although rare, participants medically treated outside of the 
community or those that recently travelled outside of the community were excluded 
for this study.  None of the participants presented here had been treated for any 
illness requiring therapeutic antibiotics. Each volunteer participant in the study was 









Freshly voided fecal samples were collected from members of the community 
and immediately processed.  Solid fecal samples collected in microcentrifuge tubes 
and swabs were processed into anaerobic transport media. Additionally, fecal slurry 
was processed onsite and added to pre-reduced sterile media and glycerol. All 
samples were transported in anaerobic jars on ice, down the river over a three-day 
period. Samples were stored on ice until arrival.  
	
Figure 10. Location of San Mateo community, located on Peruvian-Bolivian border 
 
 
Initial resistance screen  
	
All antibiotics used throughout this study, corresponding molecular targets 






selected by screening, utilizing a disk diffusion method developed in collaboration 
with the Dr. Lars Hansen Laboratory, Aarhus University, Denmark. Samples from 
four healthy individuals were used in this investigation. In consultation with the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
(https://mic.eucast.org/Eucast2/) and the Clinical and Laboratory Standards Institute 
(CLSI) (https://clsi.org/standards/products/iso-documents/), the screening process 
was standardized to enhance current databases. Dilutions of 1 g solid fecal material 
(1/5, 1/10 and 1/100) were inoculated on Mueller Hinton (MH) agar (Oxoid) 
amended with 5% blood. Antibiotic discs (BD BBL) were applied to the agar and 
incubated for 24 hours at 37°C under aerobic conditions or anaerobic conditions 
using a gas mix of 85 % nitrogen, 10 % carbon dioxide, and 5 % hydrogen at 37°C. 
All plates were prepared in triplicate.  
The antibiotic discs used for the screening process included β-lactams, 
aminoglycosides, tetracyclines, quinolones, macrolides, lincosamides, and 
chloramphenicol (Table 30).  Resistant colonies were selected from within the zone 
of inhibition that surrounded each disc. Resistant organisms were plated onto MH 
agar supplemented with 5% blood at 37°C and repeated until a pure culture was 
obtained. Isolates were stored in glycerol stocks (-80°C) after pure cultures were 






Table 29. Antibiotics in this study, targets and modes of resistance 



























































Quinolones Ciprofloxacin Nalidixic Acid 
DNA replication 
Topoisomerase 










Table 30. Antibiotic concentrations for resistance screen by disc diffusion 
Antibiotic Concentration Incubation Conditions 
Ampicillin 2 µg Anaerobic 
Ampicillin 10 µg Aerobic 
Amoxicillin 30 µg Anaerobic 
Carbenicillin 100 µg Aerobic 
Penicillin 2 IU Anaerobic 
Cefaclor 30 µg Anaerobic 
Cefaclor 30 µg Aerobic 
Ceftriaxone 30 µg Aerobic 
Kanamycin 30 µg Aerobic 
Doxycycline  30 µg Anaerobic 
Minocycline 30 µg Anaerobic 
Oxytetracycline 30 µg Anaerobic 
Tetracycline 5 µg Aerobic 
Ciprofloxacin 5 µg Anaerobic 
Ciprofloxacin 5 µg Aerobic 
Nalidixic Acid 30 µg Aerobic 
Erythromycin 2 µg Anaerobic 
Erythromycin 10 µg Aerobic 
Clindamycin 5 µg Anaerobic 
Chloramphenicol 30 µg Aerobic 
 
 
Phylogenetic analysis of strains 
Upon isolation of resistant strains, chromosomal DNA was extracted by 
UltraClean Microbial DNA Isolation Kit (MO BIO Laboratories, Inc). Amplification 
of the 16S rRNA gene was achieved using universal primers, corresponding to 
positions 8-27 (forward primer) and 1492-1510 (reverse primer) of the Escherichia 
coli numbering system (Hutson et al., 1993). The amplified products were treated 
with ExoSAP-IT to remove unincorporated primers and dNTPs (USB Corporation) 
and directly sequenced with primers directed towards the conserved positions of the 




The closest known related strains were retrieved from GenBank and EzTaxon 
databases and aligned with the newly determined sequences using the program 
SEQtools (https://www.ncbi.nlm.nih.gov/genbank/; 
http://www.ezbiocloud.net/eztaxon; Yoon et al., 2017, Kim et al., 2012, Rasmussen, 
2002). The resulting multiple sequence alignment was corrected manually using the 
program GeneDoc (Nicholas et al., 1997). A phylogenetic tree was constructed 
according to the neighbor-joining method (Saitou & Nei, 1987) with the programs 
SEQtools and TREEVIEW (Page, 1996).  The stability of the groupings was 
estimated by bootstrap analysis (1000 replications).  
 
 
Antimicrobial susceptibility testing 
	
All antimicrobial susceptibility testing was performed according to the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the 
International Organization for Standardization (ISO) guidelines. Stock solutions 
were prepared for the 15 antibiotics (Table 31) and filter sterilized. Working 
solutions were created in Mueller Hinton (MH) broth from each stock solution 
according to EUCAST break points and the upper limit growth (Table 31).  
The range of concentrations selected was compared to reference strains in 
EUCAST database, when available (https://mic.eucast.org/Eucast2/) (Fig A1). The 
range allowed for endpoint minimum inhibitory concentration (MIC) determination. 




An inoculum was prepared in anaerobic or aerobic MH broth based on 
isolation conditions, from colonies grown on BHI + 5% blood from 24-hour growth 
at 37°C. The inoculum was prepared to a turbidity equivalent of 0.5 McFarland 
standard. To each antibiotic solution, 50 µl of inoculum was added for a final volume 
of 100 µl /well. Each antibiotic solution was tested in triplicate. Escherichia coli 
strain ATCC 25922 was also tested as a control and compared to previously reports 
and CLSI and EUCAST databases.  
The 96-well plates were incubated for 24 hours at 37°C under anaerobic or 
aerobic conditions corresponding to the original isolation conditions. A volume of 
100 µl inoculum was added to the wells without antibiotic solution and an aliquot 
was plated onto BHI + 5% blood agar after incubation to ensure purity. Sterility of 
uninoculated antibiotic solution wells was verified after incubation by plating onto 










Whole genome sequencing and assembly 
	
Whole genome sequencing (WGS) was employed for functional genomic 
analysis and to resolve phylogenetic relationships. The genome of resistant isolates 
was sequenced using an Illumina MiSeq sequencing platform (Illumina, CA). 
Library preparation, sequencing, and runs were performed in accordance with the 
manufacturer’s instructions. Genomic library construction was performed by by the 
Laboratories of Molecular Anthropology and Microbiome Research under the 




Draft genomes of closely related species, based on 16S rRNA sequence % 
similarity, were selected as comparison strains. All microbial genomes were 
downloaded from the National Center for Biotechnology Information (NCBI).  
Average Nucleotide Identities (ANI) of all resistant strains and related taxa were 
calculated using the OrthoANIu algorithm (https://www.ezbiocloud.net/tools/ani) 
(Lee et al., 2016, Yoon et al., 2017). The program RNAmmer (1.2 server) was used 
to predict 16S rRNA genes from genome sequences to confirm the initial identities 
of these organisms (Lagesen et al., 2007). Draft genomes sequences were 
investigated for the presence of ARGs using the Comprehensive Antibiotic 
Resistance Database (CARD) (version 1.1.8) (McArthur et al., 2013, Jia et al., 




(Seemann, 2014). Output files was analyzed using the Resistance Gene Identifier 
(version 3.2.0) to predict resistance genes based on homology and single-nucleotide 
polymorphism (SNP) models.  Additionally, results were verified by standard 
BLASTP search against the CARD reference sequences and manually compared.  
Only those predicted AR genes with ≥60% similarity to the reference sequences 
were included (Fig A2). This value was chosen as a cutoff as AR genes	<60% could 
be the result of novel genes or significant divergence from known mechanisms 
available in the database that CARD is able to recognize. This cut-off restricts the 
detection of more distant homologs and ensures the detected variant is likely a 
functional ARG.  The resistance gene analysis of each strain was compared between 







Initial resistance screen and phylogenetic analysis 
	
Resistant colonies were observed to all antibiotics in the initial disc diffusion 
resistance screen with the exception of minocycline. Only those organisms from well 
inside the zone of inhibition were selected. Of the 200 organisms originally isolated, 
the focus of this chapter is restricted to 64 strains based on phylogenetic analyses so 
representatives of different taxa were represented. Resistant organisms were isolated 
from both anaerobic and aerobic cultivations from each of the four participants, with 
a total of 15 strains from Matses1, 17 strains from Matses20, 15 strains from 
Matses31 and 17 strains from Matses33 (Table 32).  Initial partial 16S rRNA gene 
sequencing revealed these resistant strains as species belonging to Bacillales and 
Lactobacillales including Bacillus spp., Paenibacillus spp., Lactobacillus spp., 
Pediococcus spp. and Lactococcus spp., and species of the Escherichia and Shigella 
cluster.  
Bacillus species were resistant to β-lactam, chloramphenicol and quinolone 
antibiotics. Paenibacillus species were resistant to β-lactam and chloramphenicol 
antibiotics.  Lactobacillus species were resistant to β-lactam and tetracycline 
antibiotics.  Pediococcus species were resistant to β-lactam antibiotics. Lactococcus 
species were resistant to quinolone, lincosamide, and βeta-lactam antibiotics. 
Escherichia and Shigella cluster species were resistant to quinolone, lincosamide, 




antibiotic disc resistant and individual in Tables 33.1-33.5. No resistant isolates were 
recovered from amoxicillin, minocycline or gentamycin. This is not indicative of 
lack of resistance to these antibiotics as the use of this methodology was conducted 
as a preliminary resistance screen using a fecal slurry rather than determination of 
resistance of pure cultures. The use of pure culture disc diffusion was not used in this 
investigation but instead MIC was determined to a range of antibiotics and 
concentrations. Prescreening the isolates ensured all strains were resistant to at least 
one antibiotic class. Determination of MIC was performed by antibiotic 
susceptibility testing and should indicate resistance determinants in the CARD 
resistome analyses.  
 
Table 32. Number of initial screen resistant strains by indigenous individual 
* 














Table 33.1 Original disc resistance to antibiotics 
 Lincosamide Macrolide Chloramphenicol 
Strain Clindamycin Erythromycin Chloramphenicol 
Total 7 1 5 
Bacillus altitudinis - - 3 
Bacillus safensis - - 1 
Escherichia/Shigella 5 1 2 
Lactococcus lactis 2 - - 
 
 
Table 33.2.  Original disc resistance to β-lactams antibiotics 
 
 
Table 33.3. Original disc resistance to quinolone antibiotics 
Strain Nalidixic acid Ciprofloxacin 
Total 10 7 
Bacillus safensis - 1 
Escherichia/Shigella 1 - 
Lactococcus lactis 8 4 
Lactococcus taiwanensis 1 2 
 
 
Table 33.4. Original disc resistance to tetracycline antibiotics 
Strain Doxycycline Oxycycline Tetracycline 
Total 3 1 1 
Escherichia/Shigella 3 1 - 
Lactobacillus ruminis - - 1 
 
 
Table 33.5. Original disc resistance to aminoglycoside 
Strain Kanamycin 






Phylogenetic and genomic analysis of strains 
Of the 64 strains from the initial disc resistance screen, 50 genomes were 
suitable for further genomic analyses. Two organisms were unable to revive from 
glycerol stocks and 12 genomes were excluded because of poor sequence assembly. 
The original identities were confirmed by the full 16S rRNA analysis predicted by 
RNAmmer from genome sequences (Table 34.1-34.5). All organisms were 
determined to be strains of previously described species. The relationships of all 
strains and closely related species are shown in the phylogenetic tree (Fig 11). ANI 
analysis was performed between resistant strains and the closest relatives based on 
16S rRNA sequencing similarity results, between the resistant strains and the related 
comparison strains, and between members of the same taxa (Table 35.1-35.4). Due 
to their very close relationships, E. coli and Shigella species were not well resolved 
based on 16S rRNA, ANI and additional analysis (not shown). Continuing 
investigations into differentiation of this group of organisms remains taxing to 
molecular microbiologists and is beyond the scope of this investigation for the 
purposes of this investigation and will be grouped together and referred to 













Table 34.1. Bacillus species identity and 16SrRNA gene sequence similarity % 
Strain designation Identity Similarity (%) 
34 IM20A11 Bacillus altitudinis 99.9 
117 M33A35 Bacillus altitudinis 100 
45 IM20A23 Bacillus altitudinis 100 
46 IM20A24 Bacillus altitudinis 100 
116 M33A32 Bacillus safensis 99.9 
52 IM20A30 Bacillus xiamenensis 100 
54 IM20A32 Bacillus xiamenensis 100 
 
	
Table 34.2. Species identity and 16S rRNA gene sequence similarity 
Strain designation Identity Similarity (%) 
132 M33A34 Paenibacillus lactis 100 
136 M33A47 Paenibacillus lactis 99.8 
137 M33A48 Paenibacillus lactis 99.9 
139 M33A50 Paenibacillus lactis 99.9 
 
 
Table 34.3. Species identity and 16SrRNA gene sequence similarity % 
Strain designation Identity Similarity (%) 
8 IM01A8 E. coli/Shigella spp 99.9 
17 IM01A17 E. coli/Shigella spp 99.9 
20 IM01A21 E. coli/Shigella spp 99.9 
21 IM01A22 E. coli/Shigella spp 99.8 
41 IM20A19 E. coli/Shigella spp 99.9 
58 IM01B1 E. coli/Shigella spp 99.9 
59 IM01B2 E. coli/Shigella spp 99.9 
63 IM01B8 E. coli/Shigella spp 99.9 
70 IM01B19 E. coli/Shigella spp 99.9 
74 IM01B26 E. coli/Shigella spp 99.9 
77 IM01B30 E. coli/Shigella spp 99.9 
133 M33A40 E. coli/Shigella spp 99.9 
163 M31A11 E. coli/Shigella spp 99.9 
169 M31A14 E. coli/Shigella spp 99.9 











Table 34.4. Lactococcus species identity and 16SrRNA gene sequence similarity % 
Strain designation Identity Similarity (%) 
4 IM01A5 Lactococcus lactis 99.8 
16 IM01A16 Lactococcus lactis 99.9 
78 IM01B3 Lactococcus lactis 99.8 
118 M33A36(3) Lactococcus lactis 99.9 
120 M33A38 Lactococcus lactis 100 
121 M33A39 Lactococcus lactis 99.9 
125 M33A46 Lactococcus lactis 100 
141 M33A57 Lactococcus lactis 99.8 
143 M33A59 Lactococcus lactis 100 
145 M33An25 Lactococcus lactis 99.9 
160 M31A08 Lactococcus lactis 99.9 
164 M31A12 Lactococcus lactis 99.9 
173 M31A18 Lactococcus lactis 99.8 
179 M31An02 Lactococcus lactis 99.8 
33 IM20A10 Lactococcus taiwanensis 99.9 
37 IM20A15 Lactococcus taiwanensis 99.9 






Table 34.5. Species identity and 16S rRNA gene sequence similarity 
Strain designation Identity Similarity (%) 
82 IM20B2 Lactobacillus ruminis 99.6 
85 IM20B6 Lactobacillus ruminis 99.9 
101 IM20B25 Lactobacillus ruminis 99.7 
105 IM20B29 Lactobacillus ruminis 99.6 















Figure 11. Phylogenetic tree showing the relationship of resistant organisms to 
closely related species. Bootstrap values (>90%), expressed as a percentage of 1000 
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Table 36.  Antibiotics used in this study, spectrum, and impact on GI tract 





Class Spectrum  Impact on GI tracta 
β-lactams Narrow and broad 
Decreased bacterial diversity, decreased 
abundance of anaerobes, greater prevalence of 
Enterobacter spp., decreased abundance of 
enterobacteria 
Aminoglycosides Broad 
Decreased bacterial diversity, greater 
prevalence of Enterobacter spp.; abundance of 
Ruminococcaceae and Bacteroidaceae 
increases 
Glycopeptides Narrow Decreased bacterial diversity 
Tetracyclines Broad 
Reduction in abundance of Bacteroidetes 
enterococci, E. coli, lactobacilli, and 
bifidobacteria and increases in other 
enterobacter and yeasts; increase in 
Proteobacteria 
Macrolides Narrow 
Decreased abundance of Streptococci, 
enterococci, and enerobacteria; increase in 
abundance of staphylococci; alteration in 
abundance of anaerobes 
Lincosamides Moderate 
Decreased abundance of enterococci, 
streptococci and anaerobic bacteria then 
recovery of abundance of streptococci and 
anaerobic bacteria, reduced diversity of 
Bacteroides spp., decrease in SCFA producers  
Phenicols Broad Lower bacterial diversity, increases in yeast  
Quinolones Narrow and broad 
Lower bacterial diversity, decrease in short-
chain fatty acid producers, decreased 




Antimicrobial susceptibility testing 
Eight classes of antibiotics were used in the susceptibility test. The classes of 
antibiotics and their attributed effect on the gastrointestinal microbial community are 
shown in Table 36. Each organism was tested in triplicate to the full panel of 15 
antibiotics. When the panel was not in agreement, the isolate was re-tested against 
the panel with fresh growth from BHI blood plates. All 96-well plates were graded 
by visual confirmation of growth, without strain information to reduce biases. MIC 
were determined and compared to EUCAST breakpoints for the organism or the 
general anaerobic breakpoint to determine resistant or susceptible classifications 
when available (Table 37.1-37.6). Many antibiotics do not have data for any of the 
screened organism. The efforts described here will benefit the EUCAST database by 
extending the MIC breakpoints of additional organisms and to additional antibiotics 
(Jorgensen & Turnidge, 2015).  When no MIC breakpoints were recorded in 
databases, values ≥64 are likely indicative of resistance and are highlighted for 
further investigation.  
All L. lactis isolates displayed resistance to nalidixic acid. Overall strains L. 
lactis strains M22A46, M33A57 and M33A59 displayed the least resistance to all 
antibiotics tested. L. lactis strains IM01A15, IM01A16, M33An25 and M31A12-B 
were resistant to all antibiotic tested. Similarly, L. taiwanensis, strain M31A13-B, 
displayed resistance to all antibiotics tested.  
Bacillus species displayed the least resistant to any antibiotics tested of all 




All Bacillus isolates were susceptible to tetracyclines and vancomycin. Overall, 
Escherichia/Shigella species were found to display the most resistance compared to 
isolates from other taxa.  All strains displayed resistance to cefalclor, ceftriaxone and 
vancomycin, 
E. coli/Shigella were tested under anaerobic and aerobic conditions to 
determine differences in MIC between conditions. Under anaerobic growth 
conditions, all strains were resistant to clindamycin, kanamycin, vancomycin, 
cefaclor and ceftriaxone. All strains but IM20A19 were resistant to erythromycin 
and carbenicillin under anaerobic conditions. All E. coli/Shigella species but strain 
M31An17 were resistant to chloramphenicol under aerobic conditions. All 
Escherichia/Shigella species but strain M31A14 were resistant to clindamycin under 
aerobic conditions. Alternatively, Escherichia/Shigella species were susceptible to 
tetracycline and oxytetracycline but strains IMO1A21, IMO1A22, M31An09, 
M31An11, M31An16 and M31A11 when grown under aerobic conditions. 
Differences in resistance between anaerobic and aerobic conditions were likely 
observed due to requirements for an oxygen-dependent carrier in order to enter the 
cell as is the case of aminoglycoside uptake.  
Paenibacillus isolates were susceptible to doxycycline, tetracycline and 
ceftriaxone. All Paenibacillus isolates were susceptible to erythromycin but strain 
M33A48, susceptible to vancomycin but strain M33A34 and susceptible to 
ampicillin but strain M33A51. All Lactobacillus strains were susceptible to 




were susceptible to clindamycin. All strains were resistant to vancomycin and all 
strains but IM20B28 were resistant to chloramphenicol, ampicillin, carbenicillin and 











































































EUCAST MIC ND ND >16R >4R ND ND >2R >8R 
G- anaerobe MIC >4R ND >8R ND ND ND ≥4 ND 
8 IM01A8 >512 128 256 128 8 4 2 256 
15 IM01A15 256 128 256 128 16 32 2 128 
17 IM01A17 256 128 256 128 8 32 4 512 
20 IM01A21 256 >32 64 128 512 256 4 16 
21 IM01A22 >32 >1024 128 >64 >128 >32 >512 64 
41 IM20A19 256 1024 64 512 32 32 512 256 
58 IM01B1 256 1024 16 1024 32 32 512 256 
59 IM01B2 >512 64 128 512 8 16 2 16 
63 IM01B8 512 64 16 8 32 4 8 16 
64 IM01B9 256 1024 256 64 16 4 1 512 
70 IM01B19 ND 8 16 ND 4 4 ND ND 
74 IM01B26 256 128 128 8 16 16 2 8 
77 IM01B30 >512 64 128 4 4 32 2 8 
133 M33A40 512 512 256 64 16 32 512 256 
163 M31A11 64 <0.5 32 2 4 64 512 8 
169 M31A14 32 64 16 1 2 4 2 16 
171 M31A16 >512 64 16 0.5 16 4 8 32 
186 M31An09 >512 64 16 16 512 128 2 8 
188 M31An11 >512 64 16 16 512 128 2 8 
191 M31An16 128 64 16 16 >1024 128 2 8 
192 M31An17 64 64 8 2 4 4 2 16 
193 M31An18 64 64 16 2 4 4 4 16 
All concentrations in mg/L;  ND, not determined in database; highlighted cells 

































































EUCAST MIC ND >8R ND >4R >0.125R ND >0.64R 
CLSI MIC ≥32 ≥32 ND ND ≥4 ND ≥4 
8 IM01A8 64 4096 > 2048 512 32 256 2 
15 IM01A15 32 8 256 256 32 256 0.5 
17 IM01A17 64 8 256 256 32 128 0.5 
20 IM01A21 64 4096 > 2048 >1024 32 128 2 
21 IM01A22 ND 256 256 256 >32 >256 >16 
41 IM20A19 256 256 32 256 32 128 8 
58 IM01B1 256 256 256 256 32 256 1 
59 IM01B2 128 4096 >2048 512 64 256 64 
63 IM01B8 1024 1024 2048 1024 32 256 1 
64 IM01B9 1024 1024 256 >1024 128 256 32 
70 IM01B19 256 ND 64 256 ND ND ND 
74 IM01B26 64 16 256 256 32 256 64 
77 IM01B30 32 8 256 256 32 256 128 
133 M33A40 256 32 256 128 32 256 16 
163 M31A11 >1024 256 1024 256 512 64 4 
169 M31A14 64 4 32 128 32 32 0.5 
171 M31A16 64 8 32 256 >1024 512 >512 
186 M31An09 64 4096 >2048 512 32 16 0.125 
188 M31An11 64 4096 >2048 512 32 32 0.125 
191 M31An16 64 >4096 >2048 512 32 2 0.125 
192 M31An17 64 8 32 128 32 2 0.125 
193 M31An18 64 8 32 128 32 2 0.125 
All concentrations in mg/L; ND, not determined in database; highlighted cells 





































































EUCAST MIC ND ND >16R >4R ND ND >2R >8R 
G- anaerobe MIC >4R ND >8R ND ND ND ≥4R ND 
8 IM01A8 512 128 16 16 64 16 4 16 
15 IM01A15 512 256 128 >1024 1024 512 4 16 
17 IM01A17 >512 256 32 1 32 32 512 256 
20 IM01A21 256 64 8 1 8 4 512 128 
21 IM01A22 >512 256 128 256 1024 256 4 16 
41 IM20A19 ND <64 32 256 128 32 128 16 
58 IM01B1 512 128 64 64 256 128 8 32 
59 IM01B2 128 3072 32 64 32 >512 128 16 
63 IM01B8 128 256 128 256 64 4 4 32 
64 IM01B9 256 128 8 128 64 >512 8 128 
70 IM01B19 256 256 128 1024 1024 32 8 32 
74 IM01B26 256 128 16 0.5 1 64 8 32 
77 IM01B30 512 128 16 256 2 >512 >3072 32 
133 M33A40 >512 64 8 1 0.5 4 4 16 
163 M31A11 256 64 16 1 0.5 4 64 256 
169 M31A14 256 64 8 16 512 128 8 32 
171 M31A16 >512 64 16 16 512 128 8 32 
186 M31An09 256 64 8 16 512 128 8 16 
188 M31An11 128 64 8 1 1 4 8 32 
191 M31An16 128 64 8 1 1 4 8 32 
192 M31An17 >512 64 8 1 1 4 8 32 
193 M31An18 256 64 16 0.25 0.5 4 4 32 
All concentrations in mg/L; ND, not determined in database; highlighted cells 










Table 37.4 contd. MIC concentrations of E. coli/Shigella species 



















































EUCAST MIC ND >8R ND >4R >0.125R ND >0.64R 
CLSI MIC ≥32 ≥32 ND ND ≥4 ND ≥4 
8 IM01A8 128 4096 >2048 1024 32 32 1 
15 IM01A15 128 4096 >2048 1024 32 2 <0.125 
17 IM01A17 512 4 64 128 16 256 128 
20 IM01A21 128 4 64 128 16 512 <0.125 
21 IM01A22 128 4096 >2048 1024 32 4 <0.125 
41 IM20A19 128 <16 16 128 16 128 8 
58 IM01B1 512 4 128 128 32 32 32 
59 IM01B2 512 64 64 256 32 1024 1 
63 IM01B8 512 4096 >2048 1024 32 4 1 
64 IM01B9 >1024 512 256 1024 32 512 256 
70 IM01B19 128 4 32 1024 32 8 >512 
74 IM01B26 64 8 32 1024 32 32 8 
77 IM01B30 128 128 32 128 32 256 64 
133 M33A40 64 8 32 128 32 8 0.125 
163 M31A11 128 4 128 256 >1024 512 64 
169 M31A14 64 2048 64 1024 32 4 0.125 
171 M31A16 512 2048 >2048 512 32 4 0.125 
186 M31An09 64 2048 >2048 512 32 1 0.125 
188 M31An11 64 8 128 128 32 1 0.125 
191 M31An16 64 8 32 128 32 1 0.125 
192 M31An17 64 1024 >2048 256 32 1 0.125 
193 M31An18 512 2048 >2048 512 32 2 0.125 
All concentrations in mg/L; ND, not determined in database; highlighted cells 










Resistome analysis  
Resistance determinants were identified by CARD RGI and verified by 
CARD curated BlastP.  RGI catalogs resistome predictions by both drug class and 
resistance mechanisms. CARD utilizes two models for the detection of AR, protein 
homolog models and protein variant models.  Resistance genes are classified as 
protein homolog models based on similarity to a curated reference sequence of 
functional homologs. Protein homolog models are categorized by three criteria: 
perfect, strict and loose. All protein homolog models predicted for the taxa reported 
here were classified as perfect or strict. Perfect classification detects matches 100% 
identical to curated reference sequences and mutations. Strict classification detects 
homolog models similar to those previously to the curated reference sequences and 
mutations with <100% matches. 
Resistant genes are classified as protein variant models when resistance genes 
may not necessarily be functional. Submitted sequences are additionally searched for 
curated sets of mutations shown clinically to confer resistance relative to wild-type. 
Protein variant models are categorized as strict or loose. All protein variant models 
for the resistant taxa were categorized as strict. Strict matches contain a previously 
detected mutation of resistance variants. The CARD RGI and BlastP investigate the 
presence of resistance genes yet the presence alone of such genes does not indicate 
with certainty whether they are expressed or functional (protein variant models). 
Therefore, alternative methods should be utilized to determine if the genes are 




conditions, influence many resistance phenotypes. Efflux systems are especially 
influenced in this manner and CARD acknowledges this with continuous curation 
and is currently developing a meta-model to detect efflux pumps and mutations that 
may indicate over-expression.  
There were differences detected in the number and type of resistance genes in 
the CARD curated RGI and BlastP databases.  RGI detected both protein homolog 
and protein variant models where BlastP only detected homolog models. Resistance 
genes were examined within taxa and between taxa. The total number of genes for all 
resistant isolates and comparison strains in the RGI database is 178 and in BlastP 
detected 131 resistance genes.   
Four resistance genes were detected in the Lactobacillus and Pediococcus 
species (Table 38.1). All were strict protein homolog models except SarpoB, which 
is a strict protein variant model. When compared to L. ruminis strain ATCC27782, 
Matses L. ruminis strains genomes IM20B2, IM20B6 and IM20B25 contained 2 
additional PmrE genes. PmrE is a gene that alters cell wall charge to confer 
resistance to polymyxin. All strains shared resistance genes ScEFTU, SarpoB and 
dfrE conferring resistance to elfamycin, rifamycin and trimethoprim respectively. No 
resistance genes were detected for any of the antibiotics tested for MIC in this study. 
It is possible that novel machinery is present for the resistance displayed here within 





CARD detected 26 resistance genes among the P. lactis strains (Table 38.2). 
All Peruvian P. lactis strains had an additional VatI gene when compared to the 
comparison strain and two additional resistance genes (otrA and vanYM).  
Comparison strain P. lactis 154 contained resistance genes, vanRM, vanSM, vanYF, 
mel, CIPa, msrE SAgyrB and clbB conferring resistance for vancomycin, macrolide, 
streptogramin, aminocoumarin and multidrug resistance.  
All Matses L. lactis genomes contained six resistance genes (Table 38.3).  L. 
taiwanensis genomes contained 6 resistance genes conferring resistance to 
elfamycin, chloramphenicol and lincosamide and general efflux pumps. Only the 
comparison strain L. lactis strain II1403 contained Mycobacterium tuberculosis rpoB 
mutants conferring resistance to rifampicin. Only resistant Peruvian strains contained 
E. coli EF-Tu mutants conferring resistance to elfamycin.  
All resistant Bacillis species contained ScEFTU, ykkC, ykkD, blt and lmrB 
conferring resistance to elfamycin, chloramphenicol and tetracycyline, and multidrug 
resistance (Table 38.4). Only comparison stains contained SagyrB and an additional 
copy of Bmph gene.  A total of 12 types of resistance genes were detected for the 
Bacillus species.  
The E. coli/Shigella cluster had ~130 resistant genes (Table 38.5). Most of 
these genes confer multi-drug resistance by efflux pumps. Genes were classified as 
perfect or strict protein homologs or protein variant models as E. coli genes are well 
represented within the CARD curated RGI and BlastP datasets.  Also present were 




protein and cell wall charge alteration. There were many observed genes that were 
shared between all strains. Some differences between comparison and Peruvian 
strains were observed. Genes unique to comparison strains included PmrA, PmrB, 
mexB and mexD (3 copies). Genes unique to Peruvian strains included APH(6)-Id, 
APH(3”)-Ib, dfrA8, afrA15, mtrD (3 copies), AAC(6’)-On8, efrB, cprR, oqxA, 
TEM-1, sul1 &2, ECUhpT, lsaA, and a second copy of EcacrA, CRP, EcemrE, 
mdtH, mdtK, mdtL, dfrE and tolC. As most of the genes are not antibiotic specific 
but multidrug resistance efflux pumps, it is difficult to determine which genes are 
responsible for displaying resistance to antibiotics tested here. To further complicate 
the issue, not all genes are well described and do not have antibiotics assigned 
specifically to the gene. The E. coli strains are of special interest as they are so well 
characterized and the genomes contained resistance genes to all classes of antibiotics 
tested, although no single organism was resistant to all antibiotics. Resistance genes 
were detected for all antibiotic classes testing in this study, accounting for the high 
level of resistance observed. Further investigation of these strains is currently 
underway. Transcriptome data will allow for determination of genes activity or 





Table 38.1. Lactobacillaceae resistance gene % similarity to database 
Resistance gene ScEFTU PmrE PmrE SarpoB dfrE 
Strain  
Lactobacillus ruminis  
ATCC 27782 70
**   71* 76** 
Lactobacillus ruminis 
82 IM20B2 69 60 60 71
* 76** 
Lactobacillus ruminis 
85 IM20B6 69 60 60 71
* 76** 
Lactobacillus ruminis  
101 IM20B25 69 63
* 64* 71* 76** 
Lactobacillus ruminis  




**   69* 70** 
Pediococcus pentosaceus 
87 IM20B9 69   69
* 70** 
* Only in Card database 



























































































Genome analysis of the Matses resistome using the CARD databases 
revealed genes encoding for resistance to the all classes of antibiotics in the study. E. 
coli/Shigella cluster contained by far the most genes as expected as these resistance 
genes were best classified and described within the CARD curated databases. The 
continued development of the CARD database will aid in the identification of 
additional resistance genes through the meta model functions. This study is but a first 
step in the investigations of the immense diversity of antibiotic resistance 
mechanisms, in the Matses microbiome. Differences between taxa specific resistance 
genes and MIC resistance determination varied greatly suggesting novel machinery 
or novel functions for previously described genes. An example of this is P. 
pentosaceus strain IM20B9 only containing three resistance determinants but 
displaying high levels of resistance to all antibiotics in susceptibility testing. 
Additionally, all Bacillus strains contained multiple chloramphenicol resistance 
strains but only B. altitudensis strains displayed resistance suggesting additional 
required mechanisms. 
Paenibacillus strain M33A34 was found to be 100% similar based on ANI 
analysis but two additional genes, TetB and LlmA, were detected when compared to 
other Matses resistance strains suggesting ANI analysis is not an adequate prediction 
of resistance gene detection between strains. Of particular interest of strain M33A34 
is gene LlmA, conferring resistance to clindamycin, which was only recently 




2016).  Similarly, the Matses resistome, also from an isolated area, has the potential 
to harbor novel machinery. Examples of novel machinery, such as gene LlmA, 
conferring resistance to clindamycin, will likely be revealed upon further 
transcriptome analyses. Strain M33AA34 did exhibit resistance to clindamycin but 
this was not unique to the strain as strain M33A49 also was resistant.  Similarly, 
MIC results showed that TetB did not uniquely confer resistance to tetracycline 
antibiotics as strains M33A34 and M33A49 were resistant  
to oxytetracycline and no strains were resistant to doxytetracycline or tetracycline. 
Lactococcus strains genomes were interesting as only 6 genes were detected 
within all genomes except L. taiwanensis strain M31A13-B which did not contain 
missing LmrC and LmrD conferring resistance to lincosamides. The four genes 
shared by all strains, EcEFTu aand ScEFTu, patB and emeA, confer resistance to 
elfamycin, rifampcin, fluoroquinone and multidrug efflux pumps respectively. 
Although strain M31A13-B contained only four resistance genes it displayed 
resistance to all antibiotics tested. Of the L. lactis strains, IM01A15, IM01A16, 
M33An25 and M31A12-B displayed resistance to all antibiotics tested as well. The 
patB confers resistance to fluoroquinone antibiotics and all strains were found to be 
highly resistant to nalidixic acid and most were resistant to ciprofloxacin. The 
occurrence of genes responsible for synthetic antibiotics is especially interesting as 
the Matses community groups have not been exposed to therapeutic antibiotics. The 
occurrence of these genes and the resistance levels of fluoroquninones suggests a 




remaining antibiotic class resistance, it would be predicted that all Lactococcus 
strains would be resistant, and as some strains are susceptible, there is likely 
additional resistant machinery present but not detected and/or the current machinery 
is poorly described.  
The E. coli/Shigella organisms contained resistance genes for all tested 
classes of antibiotics and overall, the genes occurred in all strains with few 
exceptions. However MIC revealed patterns of sporadic resistance that were not well 
correlated to the genes. This is most likely due to the regulation of efflux 
mechanisms (Blair et al., 2015). This study has only begun to scratch the surface of 
the immense diversity of antibiotic resistance machinery in the Matses microbiome. 
Finally, the diversity in the resistome also suggests that there are a myriad of 
bioactive molecules with antibiotic properties waiting to be discovered. Some of 








Moving forward to reduce resistance  
Historically, it is commonly accepted that antibiotics have been over 
prescribed and used where not appropriate. Even when antibiotics are prescribed 
appropriately, often they are not taken as directed with patients opting to stop taking 
an antibiotic when they feel better and therefore not completing treatment regiments.  
The consequence is that organisms are not completely killed off, leading to resistant 
organisms that proliferate.  The widespread use of antibiotics in agriculture can serve 
as a driver for evolution and spread of bacterial resistance. 
In 2016, only five of the top 50 drug companies were actively developing new 
antibiotics.  While the reasons for the sharp decline in antibiotic trials are numerous, 
one glaringly, obvious reason is the expense.  Since 1995, one company still actively 
pursuing antibiotic research and design, GlasxoSmithKline analyzed some 300 new 
antibiotic targets at an estimated cost of $1.6 billion. Of the 300 targets, only 7 
percent resulted in initially promising leads but all ultimately failed in clinical trials 
(Jones, 2010, Czaplewski et al., 2016).  Other key reasons for the lack of novel 
antibiotics are the time intensive research and development process and safety 
considerations of the compounds. In many cases, promising compounds are not 
considered tolerable or safe at the high concentration required to work effectively. In 
instances where a patient is already very ill, the drug candidates must be both safe 




Yet another challenge to the development of new antibiotics is the lack of business 
incentives. For years there has been an inverse relationship between the challenges 
and rising occurrence of antibiotic resistance and the incentives and rewards to 
address the issue.  Only recently, the federal government passed rules that have 
ushered in the development of dozens of new drugs by extending market exclusivity 




Antibiotic stewardship programs and education workshops help to preserve 
the effectiveness of antibiotic treatments.  Recently, former President Barack Obama 
proclaimed November 13 – November 19 as Get Smart About Antibiotic Week and 
called for medical professionals and scientists to observe the week by “promoting the 
responsible use of antibiotics and raising awareness of the dangers inherent in their 
misuse and overuse”. Furthermore, at a White House hosted forum, a directive was 
issued that directed the federal government to purchase meats from sources that 
follow responsible antibiotic use and that have raised animals in accordance with the 
same responsible-use policies.  Programs like the National Action Plan for 
Combating Antibiotic-resistant bacteria (https://www.cdc.gov/drugresistance) and 
the WHO Global Action Plan on Antimicrobial Resistance 
(http://www.wpro.who.int/topics/drug_resistance/en) highlight the issue in a 
collaborative effort to not only to better inform the public but also to identify key 




Action Plan also provides an improved Federal fund set aside to combat and prevent 
antibiotic resistance totaling more than $1.2 billion. Programs like the FDA and 
CDC’s antibiotic stewardship program - the Get Smart Campaign 
(https://www.cdc.gov/getsmart/) – help ensure that patients better understand their 
antibiotic treatment program.  These programs provide information for the patient 
about taking the right antibiotic at the right dosage for the prescribed amount of time, 
which improves consumer and provider education around appropriate antibiotic 
usage and the spread of resistance (Fig 12). 
 Ongoing stewardship activity has been shown to have the most measureable effects 
on inappropriate antibiotic use in a recent report by the Pew Charitable Trusts (PCT). 
Understanding the origin and mechanisms of ARGS can further contribute to the 
development and expansion of promising new antibacterial drug candidates and new 






Figure 12. Examples of the Center for Disease Control initiative Get Smart About 





Understanding the role of the intestinal microbial community and its complex 
relationship with the host is of great importance. The diverse taxa that reside within 
the gastrointestinal microbial community are routinely identified through gene 
sequencing and cultivation methods that allow for discerning novel species diversity 
and provide insights into their function within the gastrointestinal tract environment. 
Despite large scale sequencing efforts, the full extent of gut microbiome remains 
unexplored. As the organisms representing most abundant phylotypes of the human 
gut continue to be cultivated and characterized, isolated microbes can provide a 
better understanding the diversity and functionality of species within this group. A 
combination of bacterial isolation and cultivation and molecular sequencing methods 
has resulted in the comprehensive classification of four new taxa. The study of novel 
species with an unknown role within the gastrointestinal tract is of considerable 
importance. The microbiome includes a community of symbionts and commensals 
that have effect on immune function and nutrient processing and the role of novel 
taxa in health or disease functions has led to unprecedented sequencing and 
cultivation efforts. Globalization affects potentially beneficial bacteria harbored in 
the human body. The developing world harbors a number of biological biases that 
are absent in the developed world. Novel taxa and novel microbial community 
profiles have been reported when compared to Western populations. Furthermore, 
isolates from these communities displayed a high level of resistance to a number of 
antibiotic classes suggesting that while antibiotic therapy is a driver of selection for 




present even when such drivers are absent. Further investigations of these organisms 
may have implications of drug discovery. The study of traditional, indigenous 
communities provides a unique opportunity to expand investigations of ‘missing’ 
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Figure A2: CARD gene information example 
	
